The sex hormones that play major roles in the neuroimmune regulatory network include gonadotropins, prolactin, estrogens, progestogens, androgens and their agonists and antagonists. The steroid hormones listed above have membrane and cytoplasmic or nuclear receptors. Nuclear receptors are transcription factors that directly regulate gene expression.
INTRODUCTION
Investigations of the interaction of the immune and nervous systems date back to the late 19 th century. Early workers noted that the size of the thymus varied according to emotional impulses and of stress [1] . Smith observed that in hypophysectomized rats the thymus involuted, but showed normal size if pituitary remnants were present [2] . The first significant research into neuroimmune interactions was conducted by the students and followers of Pavlov in Russia. These workers concluded that the hypothalamus regulates immune function [3] . Andor Szentivanyi investigated first the role of the hypothalamus in immune function using objective scientific methodology. He observed with his colleagues, that hypothalamic lesions inhibited the development of anaphylactic shock in immunized animals [4] . Hypothalamic tuber cinereum lesions (TBL) inhibited anaphylaxis in pre-immunized guinea pigs and in later experiments also in rabbits. Anaphylaxis was elicited in immunized animals by the intravenous injection of the immunizing antigen. Antibody production was also inhibited if TBL was done prior to immunization. TBL did not affect the reaction of antibodies with the specific antigen, nor did the release of tissue materials mediating anaphylaxis. Hypothalamic lesions temporarily increased the resistance of the animals to histamine and inhibited the anaphylactic reaction even when the animals were provided with passively transferred antibodies, which elicited lethal shock in control animals. The Schultzdale test, which was performed with small pieces of intestine in vitro, was also inhibited by TBL. The Arthus reaction, turpentine induced inflammation and the SanarelliSchwartzmann phenomenon were unaffected. Lesions of other areas of the hypothalamus or of the central nervous system were ineffective in modulating immune function. Further, electrical stimulation of the mammillary region of the hypothalamus had an inhibitory effect on the anaphylactic response and increased the resistance of animals to histamine [5] [6] [7] . In 1964, Korneva and Khai [8] confirmed that hypothalamic lesions in rabbits, guinea pigs and rats inhibited the production of complement fixing antibodies.
In 1936, Hans Selye described the stress syndrome, which has been elicited in rats by various "nocuous' agents. The first report was published in the Nature [9] and second article in the British Journal of Experimental Pathology [10] . He demonstrated that the involution of the thymus was mediated by the adrenal gland as it was absent in adrenalectomized animals after stress. This observation led to an extensive study of steroid compounds in rats and also in chicken. He was the first to establish that the bursa of Fabricius is an organ which is extremely sensitive to steroid hormones [11] . By 1946 Selye had a considerable amount of experimental data on the "general adaptation syndrome" which was presented in a review published in J Clin Endocrinol [12] as the first comprehensive outline of the stress concept.
During the mid 1980s, an interest was renewed in neuroimmune regulation and numerous laboratories began to investigate the interaction of the systemic regulatory circuit comprised by the nervous -, endocrine -and immune systems. By now this area has developed into a credible exact area of Biology, designated as Neuroimmune Biology. At present several books and as many as 5 scientific journals report on the research done in this field.
THE HYPOTHALAMUS -PITUITARY-GONADAL -IMMUNE AXIS (HPG)

The Central Nervous System (CNS)
In the brain, the principal hormones of the HPG axis directly interact with astroglial cells. Thus, luteinizing hormone releasing hormone, LHRH, influences hypothalamic astrocyte development and growth, and hypothalamic astrocytes direct LHRH neuron differentiation. Hormonally induced changes in neuron-glial plasticity may dictate major changes in CNS output, and thus actively participate in sex dimorphic immune responses. There is sex dimorphism in the expression of genes encoding for hormones and their receptors within the thymus, and circulating sex steroids are modulated during development and immunization. The hypothalamic-pituitary-adrenocortical (HPA) assumes a central role in communication between neuroendocrine and immune systems [13] .
Leptin, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) interact with related class-I receptors, which are expressed in the hypothalamus. Leptin and CNTF share functional similarities, by acting at hypothalamic and pituitary levels, and their receptors are co-localized in the arcuate and paraventricular nuclei of the hypothalamus. LIF affects gonadotropin secretion and stimulates GnRH secretion in vitro [14] .
Complement C5a receptor (C5aR) was detected in magnocellular neurons in the supraoptic and paraventricular nuclei of hypothalamic slices of rats. Gonadotropin-releasing hormone (GnRH) producing neurons in the preoptic area of mice also expressed C5aR. E2 stimulated C5aR expression and calcium turnover in such neurons [15] .
Haloperidol is a dopamin D2 receptor antagonist used in the treatment of schizophrenia. Haloperidol increases prolactin (PRL) release, which modulates immune activity. Longterm haloperidol treatment and E2 increased macrophage spreading, phagocytosis and NO release in male and female rats. Corticosterone and prolactin serum levels were increased after acute and long-term haloperidol treatments in rats, being this increment higher in females [16] .
LPS-injected male BALB/c mice showed increased plasma corticosterone, decreased plasma prolactin as did controls. In such mice c-Fos-positive catecholamine (CA) neurons in the medullary (A1, A2, C1, C2), and in pontine (A6) and midbrain (A10) cells were more increased than controls. Plasma prolactin correlated with c-Fos-positive CA neurons in the area postrema, the medullary CA cell groups, the medial posterior division of arcuate, and zona incerta [17] .
The significance of autoantibodies to dopaminergic nerve terminals in patients has to be confirmed. Nonetheless, the heterogeneous neuroendocrine structures of the median eminence are shown as potential immune targets, relevant to autoimmune polyendocrinopathy, and to a wide range of other conditions [18] .
Gonadotropin-Releasing Hormone (GnRH)
GnRH and sex steroids are important in immune regulation and development. Both GnRH and the GnRH receptors are produced by immune cells, which indicate an autocrine role for GnRH. Exogenous GnRH stimulates the immune response. There is evidence for an extra-pituitary GnRHimmune regulatory pathway [19] .
Galanin-like peptide (GALP) stimulates the release of GnRH from hypothalamic explants and GT1-7 cells. GALP antiserum blocks the stimulatory action of leptin on GnRH release from hypothalamic explants. GALP binds to galanin receptors, and stimulates GnRH release from hypothalamic explants, which was attenuated (but not abolished) by the galanin receptor antagonist galantide. GALP-stimulated GnRH release from GT1-7 cells was not diminished by galantide. None of the cloned galanin receptors were expressed in GT1-7 cells. GALP may stimulate GnRH release through a galanin receptor and via a direct action on GnRH neurons, possibly through a novel receptor [20] .
Estrogens exerted a stimulatory effect on B cell proliferation and serum IgG levels in GnRH sufficient but not in GnRH deficient mice. Testosterone exerted suppressive effects on B cell function in the presence of GnRH but not in its absence. Androgens and estrogens affected T cell functions irrespective of the presence and absence of GnRH [21] .
GnRH exacerbates murine lupus in a gender-specific fashion. Gender differences in immunologic responsiveness to GnRH may relate to differences in signal transducers through which GnRH acts, namely, the G proteins, Gs, and Gq/11. There were gender differences in second messengers for GnRH, IP3, and cAMP in immune cells. GnRH agonist increases the quantities and/or activity of G proteins in immune cells in a gender-specific fashion [22] .
GnRH, GnRH-R, and patterns of prohibitin (PHB) show characteristic polarized expression in thymocytes. In addition, GnRH and PHB were coexpressed in mature splenic T cells. PHB and GnRH are involved in thymic growth and may be important for maturation of T lymphocytes [23] .
Both GnRH and estradiol significantly increase the expression of GnRH-R mRNA in immune cells [24] . Treatment of normal B lymphoblastoid cells (B-LCLs) with GnRH-I or with IL-2 increased significantly cell proliferation as compared with untreated controls. IL-2 and GnRH-I induced greater proliferation in normal B-LCLs than IL-2 treatment alone. Co-incubation of IL-2 and IL-2 + GnRH-I with a GnRH antagonist (Cetrorelix) significantly attenuated the proliferation in normal B-LCLs. GnRH-II had no effect [25] . GnRH is a Th-1 lymphocyte inducer and Th-2 lymphocyte inhibitor. GnRH can shift the cytokine balance to Th-1 type in pregnancy, leading to abortion in rats [26] .
Endotoxin suppressed the amplitude of GnRH-induced LH pulses. Thus, endotoxin inhibits pituitary responsiveness to GNRH [27] . IL-1b mRNA and protein expression in cultured human endometrial stromal cells was significantly enhanced, and IL-1ra mRNA and protein was significantly decreased by GnRH-agonist in comparison to controls. The regulatory effects of GnRH agonist on IL-1b and IL-1ra mRNA and protein were ablated by GnRH-antagonist in a dose-dependent manner [28] .
GnRH Analogs
Leuprolide--a GnRH agonist--prevented stress-induced decrease in relative weights of thymus, total leukocyte count and humoral and cell-mediated immune reactions. GnRH antagonist given i.c.v. prior to leupeptide, did not alter the immunological effects of leuprolide. Castraion or ovariectomy had no effect [29] .
Surfagon, a synthetic analog of gonadotropin-releasing hormone injected before stress dose-dependently increased the number of antibody-producing cells in rats and phagocytic and functional activities of neutrophils in mice. In castrated animals this peptide increased all studied parameters [30] .
Ant. In neonatal marmosets, the GnRH antagonist, Ant, decreased B cells and T cells in the thymic medulla and T cells in the periarterial lymphatic sheaths (PALS) of spleen. In neonatal rhesus monkeys, Ant treatment increased the frequency of clinical problems, lowered circulating levels of lymphocytes, total T cells, CD8+ T cells and B cells, and altered lymphocytes response to mitogens. In adults, immune function remained impaired [31] .
Chorionic Gonadotropin (CG)
Kisspeptin and its receptor, the G protein-coupled receptor 54, play an important role in reproduction. Reproductive disorders in metabolically disrupted animals are caused by the alteration of hypothalamic KiSS-1 systems. LPS injection decreased hypothalamic KiSS-1 mRNA expression and plasma LH levels in ovariectomized rats. Indomethacin blocked the suppressive effects of LPS on LH secretion and KiSS-1 mRNA level. Intravenoous injection of kisspeptin increased plasma LH levels in LPS-administrated rats to the same degree as in saline-injected rats [32] . Toll like receptor (TLR)-3 and TLR 9 agonists upregulated hCG production in the choriocarcinoma cell line cells [33] .
hCG treatment decreases cell proliferation and increases apoptosis in endometrial cells. hCG stimulates FasL mRNA and protein expression without affecting Fas mRNA in these cells. In co-culture experiments, hCG-treated endometrial cells induce an increase in T cell apoptosis. Cells of early pregnancy decidua express strong FasL immunoreactivity, and decidual areas containing interstitial cytotrophoblasts have numerous apoptotic cells [34] .
The effect of insulin, oxytocin, gonadotropin and epidermal growth factor on the production of ACTH, endorphin, triiodothyronine in immune cells was studied. The effects fell in the following order:oxytocin > gonadotropin > EGF > insulin. Oxytocin affected 8/12 of the hormone/cell group and insulin affected only 4/12. ACTH production was reduced everywhere except in the insulin-thymocyte setup. Endorphin and T3 production was always elevated. Cells of the monocyte-grannulocyte group were more sensitive to hormonal regulation than peritoneal lymphocytes [35] .
In male lizards gonadotropins maintain physiological, morphological, and behavioral traits, as well as affect immune function [36] .
Effects of CG, estradiol, progesterone, and their physiological combinations on apoptosis of human peripheral blood T-lymphocytes were studied. There was no effect on spontaneous apoptosis of T-cells. On stimulation with mitogens, a high dose of CG (100 IU/ml) significantly increased apoptosis of T-lymphocytes, but its combination with steroid hormones specific for trimester I of pregnancy decreased this parameter: Apoptosis of T-lymphocytes induced by anti-CD95 was suppressed by a high dose of progesterone (100 ng/ml) and also by its combination with CG and estradiol specific for trimester III of pregnancy [37] . In pregnancy, the immune and the endocrine system cooperate to ensure that the fetal allograft develops without eliciting a maternal immune response. hCG and E2 inhibit the T-cell stimulatory capacity of DCs [38] . hCG produced by trophoblasts attracts Treg to the fetal-maternal interface. High hCG levels at very early pregnancy stages ensure that Treg migrate to the site of contact between paternal histocompatibility Ags and maternal immune cells and to induce immune tolerance toward the fetus [39] . In mice hCG contributes to the controlled inflammatory state of pregnancy by regulating macrophage proinflammatory function [40] . The endometrial lining of the human uterus contains a population of phenotypically distinct (CD56(bright), CD16(dim)), tissue-specific, natural killer (uNK) cells that is important for conception. An increase in the number of endometrial uNK cells occurs when the conceptus implants, and there is a further increase during the early stages of placentation. hCG, a glycoprotein synthesized by the preimplantation conceptus, is a novel regulator of uNK cell proliferation. The impact of hCG on uNK cells was mediated by mannose receptor (CD206) [41] .
Upon hCG treatment in combination with LPS, mouse bone marrow-derived DC (BMDC) increased the ratio of IL-10:IL-12p70, down-regulated TNF-alpha, and decreased antigen-specific T cell proliferation. Addition of hCG together with LPS and IFN-gamma blocked MHC class II upregulation, increased IL-10 production, and decreased the antigen-specific T cell proliferation by DC. Splenic DC showed similar results. To study the effect of hCG on DC differentiation from precursors, BMDC were generated in the continuous presence of hCG. Under this condition, hCG decreased cytokine production and the induction of T cell proliferation [42] .
Human monocytes respond to HCG and secrete IL-8 through a pathway different from the HCG receptor system, suggesting that HCG reacts with immune cells early in pregnancy, probably via C-type lectins [43] .
The Pituitary Gland
LPS stimulates intrapituitary IL-6 production in folliculostellate cells via specific receptors and the p38a mitogenactivated protein kinase/nuclear factor-kappa B pathway. ACTH secretion was also significantly enhanced by LPS. Other hormones, such as GH or PRL, were less stimulated. My4, an antibody that blocks the interaction of LPS with the LPS receptor CD14, suppressed both LPS-induced IL-6 and ACTH secretion in aggregate cultures. A neutralizing antibody against mouse IL-6 also inhibited LPS-induced ACTH secretion in aggregates. In mouse pituitary fragments, LPSinduced ACTH secretion was blocked by My4 and IL-6 antibodies, identically to re-aggregate cell cultures [44] . Pituitary cells directly respond to fungal cell wall glucans that stimulate pituitary cell TLR4 and CD14 gene expression. Glucan stimulates the secretion of prolactin, an immunoregulatory hormone [45] .
Steroid pituitary hormones were measured in the blood from 78 young Gabonese women with chronic filarial infections. Progesterone was unchanged and all other steroid hormone plasma concentrations were lower in microfilaremic women than in amicrofilaremic women. LH was higher in amicrofilaremic women, whereas prolactin was higher in microfilaremics. Plasma TNF-alpha, IFN-gamma, IL-1 and IL-6 were higher in microfilaremic women. A strong negative correlation was found between the steroid and pituitary hormones and the pro-inflammatory cytokines. Conversely, a strong positive correlation was found between prolactin and the same cytokines [46] .
Luteinizing Hormone (LH)
There is interplay between LHRH, growth factors, estrogens and pro-inflammatory mediators. This intersystem cross-talk has plasticity and is important for neuron-glial interactions as key regulators of neuroendocrine axes [47] .
CNTF regulates the preovulatory LH and PRL surges in the rat [48] .
In rats neonatal LPS challenge reduces the sensitivity of male reproductive function to the suppressive effects of LPS, mainly at the central level. Attenuation of proinflammatory cytokine synthesis in the hypothalamus might be involved in this alteration [49] . IL-1beta-induced suppression of the LH surge is mediated through an increase in GABA levels in the medial preoptic area, which causes a reduction in NE levels. By this mechanism IL-1beta inhibits reproductive function [50, 51] .
Folliculus Stimulating Hormone (FSH)
Hypogonadal bone loss is caused, at least in part, by enhanced FSH secretion, which increases TNFalpha production to expand the number of bone marrow osteoclast precursors.
Ascorbic acid may prevent FSH-induced hypogonadal bone loss by modulating the catabolic actions of TNFalpha [52] .
PROLACTIN (PRL) [53, 54]
In a 31-year-old male patient with a homozygous inactivating mutation in the STAT5b gene GH secretary parameters were normal, but there was increased (40%) body fat. The regularity of GH secretion was diminished. Prolactin was increased by six fold. There were small increases in IGF-I and IGF-binding protein-3 on lower GH doses and an increase in IGF-I to -2.4 SDS on the highest dose of GH. GH and prolactin secretion were increased in this patient [55] .
T-bet is a key transcription factor directing T helper type 1 inflammatory responses, is regulated by female steroid hormones in human mucosal epithelial cells via Stat1 and 5 pathways. T-bet was also modulated in a CD4+ T cell line by prolactin. Prolactin rapidly induced T-bet transcription through phosphorylation of JAK2 and Stat5, but not Stat1. Phosphorylated Stat5 then bound to the T-bet regulatory region. Upon long-term prolactin exposure, low-dose prolactin induced T-bet expression, whereas high-dose prolactin tended to suppress it. Prolactin induced the suppressors of cytokine signaling (SOCS) 1 and 3 in a dose-dependent manner. With high-dose exposure, this was associated with an inhibition of the phosphorylation of T-bet regulatory region-bound Stat5 [56] .
In leukocytes PRL expression is directed by an alternative promoter, located 5800 bp upstream of the pituitary promoter. This promoter is activated in myeloid leukemic cells by TNF-alpha, which can be blocked by the protein kinase C (PKC)-inhibitor GFX109203. The TNF-alpharesponsive region is located between -1842 and -1662 of the extrapituitary PRL promoter [57] .
Studies in primary cultures of pituitary cells from very young mice have shown that growth hormone secretagogue receptor (GHS-R1a) agonists, including ghrelin, increase expression of the pituitary-specific transcription factor (Pit-1), which induces the differentiation of pituitary cells into somatotrophs, lactotrophs, and thyrotrophs. Pit-1 mRNA levels are significantly lower in the pituitary gland of Ghsr-/-mice compared to wild-type littermates and also with advancing age. This is associated with reduced mRNA and fewer cells producing GH and PRL. Ghsr-/-mice had lover plasma IGF-1 and modestly reduced body weight. There was enhanced thymic involution and reduced thymic output in Ghsr-/-mice [58] .
PRL enhanced JAK2 phosphorylation in PBMC but not in granulocytes. PRL also induced phosphorylation of Stat-5 in PBMC and Stat-1 in granulocytes. PRL induced iNOS and CIS mRNA expression in granulocytes. Increased expression of IRF-1 and SOCS-2 was observed in granulocytes and of SOCS-3 and iNOS in PBMC [59] .
Human peripheral blood granulocytes, which express GH and PRL mRNA, contain high molecular-weight immunoreactive variants of GH and PRL (37 and 43 kDa, respectively), but not the pituitary-sized hormones. Secretion of these variants was not detected. Leukemic myeloid cells secrete 23-kDa PRL, which is biologically active [60] .
A specific relationship exists among leptin, PRL, IL-6, and TNF-alpha in the modulation of SOCS-1. Leptin and PRL enhance SOCS-1 gene expression in the mouse mammary epithelial cell line HC11. High concentrations of leptin (100 nM) and/or PRL significantly reduce the inhibitory effect of IL-6 and TNF-alpha on beta-casein gene expression in HC11 cells transfected with pbetacCAT [61] .
The alpha-MSH antagonist, agouti-related protein (AGRP), found in the hypothalamus, stimulates food intake by antagonizing the effects of alpha-MSH at specific melanocortin receptors. AGRP stimulated the release of PRL and cortisol in IL-1 beta stimulated ovariectomized rhesus monkeys in a dose dependent manner. The effects of AGRP on ACTH, cortisol, and PRL release were prevented by alpha-MSH infusion [62] .
In eleven healthy female volunteers domperidone administration resulted in a significant increase in PRL concentrations. During hyperprolactinemia, the hydrocortisone (HC)-induced increase in CD11b+CD8+ cells was significantly (p < 0.05) attenuated at 4 h [63] .
PRL-induced activation of macrophages in vitro is dependent on JAK/ STAT and JNK MAPK-signaling pathways [64] . Macrophage functions are regulated by an endogenous dopaminergic tone. Both PRL and dopamine exert their action by acting directly on the peritoneal macrophage [65] . Significantly enhanced production of cytokines IL-1beta, IL12p40 and IFN-gamma was observed on treatment of macrophages with PRL or GH. However, higher doses of PRL (1000 ng/ml) induced the production of antiinflammatory cytokine IL-10, with significant abrogation in production of proinflammatory cytokines. PRL and GH induced the production of chemokines MIP-1alpha and RAN-TES. PRL but not GH selectively induced significantly enhanced production of MCP-1 and IP-10. p38 MAP kinase, STAT3 and NF-kappaB could play a differential regulatory role in PRL or GH induced production of cytokines by macrophages [66] . In vitro treatment of macrophages with PRL increased both heme oxygenase-1 (HO-1) expression and protein synthesis. PRL-treated macrophages released vascular endothelial growth factor (VEGF) [67] .
Human chitotriosidase (Chit), a chitinolytic enzyme, is a member of the chitinase family. The effect of PRL was investigated in human monocyte-derived macrophages (HMMs) on Chit production. Administration of PRL in HMMs was found to increase both expression and activity of Chit in a time and dose dependent manner and also showed an enhanced release of superoxide anion (O2-) [68] .
In murine spleen CD11c-positive dendritic ells (SDCs) PRL increased viability and stimulatory capacity, upregulated MHC-11 and CD40 while decreased CD54. Further, PRL decreased the level of NF-kappaBp65 and endocytosis by SDCs. PRL increased the expressions of IL-6, IL-10, IL-12 and TNF-alpha in SDCs [69] .
Recombinant human prolactin (rhPRL) was administered to huPBL-SCID mice 10 mug rhPRL every other day for 10 injections. rhPRL significantly increased the numbers of human CD3+ T cells and human CD19+ B cells in spleens lymph nodes, and thymuses of such mice. huPBL-SCID mice were then given various doses of diphtheria-tetanus (DT) vaccine and 10-mug i.p. injections of rhPRL. rhPRL greatly improved the engraftment of functional human lymphocytes (CD3+ T cells and CD19+ B cells) in DTimmunized huPBL-SCID mice. The rhPRL-treated, DTimmunized huPBL-SCID mice produced significantly larger amounts of DT-specific antibodies in response to the vaccine. The predominant Ig isotype induced after immunization was IgG [70] .
Persistently elevated serum prolactin levels interfere with B cell tolerance induction by impairing BCR-mediated clonal deletion, deregulating receptor editing, and decreasing the threshold for activation of anergic B cells, thereby promoting autoreactivity in female BALB/c mice [71] . Elevated PRL antagonizes apoptosis in thymocytes exposed to GCs in vivo. These observations suggest that, under conditions of increased GCs, such as during stress, elevated PRL functions physiologically to maintain survival and function of Tlymphocytes [72] .
In BALB/c mice transgenic for the heavy chain of an anti-DNA antibody prolactin induced a lupus-like phenotype with an increased number of transgene-expressing B cells, elevated serum anti-DNA antibody titers, and glomerular immunoglobulin deposits. Prolactin decreased transitional B cells and increased mature follicular and marginal zone B cells. DNA-reactive B cells had a follicular cell phenotype. Bcell expansion and activation was dependent on the presence of CD4(+) T cells. Prolactin was unable to break tolerance in R4A-gamma2b transgenic C57Bl/6 mice [73] .
It was shown that 5ng/mL bPRL enhances approximately 3-fold the internalization of S. aureus (ATCC 27543) into bMEC. bPRL is able to up-regulate the expression of TNFalpha, IL-1beta and iNOS mRNAs. However, bPRL together with S. aureus did not modify the expression of TNF-alpha and iNOS mRNAs, while it down-regulated the expression of beta-defensin and IL-1beta mRNAs, as well as nitric oxide production [74] . PRL, at concentrations achievable during pregnancy, anesthesia and medication, significantly amplified IL-12 and TNF-alpha synthesis in LPS-stimulated cultures, in a dosedependent manner. Conversely, synthesis of the antiinflammatory cytokine IL-10 only increased significantly at very high concentrations of supplemented PRL. PRL, by itself or in combination with LPS, causes an increase in the binding activity of the transcription factors nuclear factorkappaB (NFkappaB) and interferon regulatory factor-1 (IRF-1), which are known to promote TNF-alpha and IL-12 secretion [75] .
Prolactin inducible protein (PIP) is a 17-kDa single polypeptide chain, functions in human reproductive and immunological systems. It is expressed in several exocrine tissues such as the lacrimal, salivary, and sweat glands. Its expression is up regulated by prolactin and androgens, and estrogens down regulate it. Its ability to bind potentially with CD4-Tcell receptor, IgG, actin, zinc alpha2-glycoprotein (ZAG), fibronectin and enamel pellicle, reveals its important biological functions [76] .
Human PBMCs obtained from healthy female volunteers were incubated with phytohemagglutinin (PHA) in the pres-ence or absence of various concentrations of PRL. PRL significantly enhanced the expression of CD69 and CD25 on activated PBMCs. Increasing doses of PRL enhanced the expression of CD69 and CD25. CD69 was enhanced on CD8+ T lymphocytes but not on CD4+ T lymphocytes [77] .
In 15 healthy blood donors human recombinant prolactin, at concentrations from 5 ng/ml to 100 ng/ml, significantly amplified IFN-gamma yields after stimulation with either PHA or LPS. PHA-stimulated cultures revealed a significant dose-dependent enhancement of IFN-gamma release [78] .
Mice treated with a molecular mimic of phosphorylated prolactin (S179D PRL) showed a profound inhibition of DTH responses to Candida correlating with an absence of GM-CSF, IL-4, and IL-13 production and a marked reduction in IL-12p70 synthesis. Circulating IgG1 and IgG2 antibody levels were increased in response to treatment with both forms of PRL, but the effects of S179D PRL were most pronounced [79] .
The expression of PRL-R mRNA in bovine lymphocytes changed in the same direction as lymphocyte proliferation with regard to photoperiod treatment, suggesting a link between photoperiodic effects on PRL sensitivity and immune function. Thus, PRL signaling may mediate photoperiodic effects on immune function [80] .
Small intestine intraepithelial lymphocytes (IEL) from rats of various ages were examined for the presence of surface prolactin receptor (PRL-R) and several lymphoid markers. Between birth and 96 days of age about 80% of IEL were found to express PRL-R. These same cells also expressed the mRNA for PRL. Rat IEL shows an age related increase in total IEL, CD4 positive cells and interleukin-2 receptor (IL-2R) expression at weaning [81] .
Unmodified and phosphorylated PRL during rat pregnancy are crucial to normal epidermal gamma delta T cell development in the pup thymus. Elevation of phosphorylated PRL in the dams, by administration of a recombinant molecular mimic of phosphorylated PRL, produces a defect in epidermal gamma delta T cell seeding and subsequent function in the offspring [82] .
Eight healthy men underwent one exercise and rest. Plasma prolactin concentrations were significantly elevated in response to exercise and correlated positively with total prolactin-receptor expression per B lymphocyte. Exercise significantly increased the number of circulating B lymphocytes expressing prolactin receptor and boosted also B cells in general [83] .
Thirty patients undergoing elective orthopedic surgery were showed significant enhancement of IFN-gamma and soluble sIL-2R release in LPS-stimulated whole blood cultures after induction of anesthesia. Similar results were observed in cultures stimulated with polyclonal T cell activators, such as staphylococcal enterotoxin B (SEB) and PHA. IL-1beta and IL-8 release was not affected, but the antiinflammatory cytokine IL-10 decreased after skin incision. Serum prolactin significantly increased immediately after induction of anesthesia, whereas serum cortisol levels declined [84] . 
Prolactin and Hematopoesis
Mice were treated with recombinant human prolactin (rhPRL) for five consecutive days after exposure to a lethal dose or a sub-dose irradiation. Prolonged survival rate and increased erythropoiesis were observed in the irradiationinduced myelosuppressed mice. rhPRL stimulated erythropoiesis and may be suitable for clinical use [86] . Recombinant rhPRL was administered to huPBL-SCID mice, 10 microg i.p. every other day for a total of 10 injections, then huPBL were transferred. rhPRL improved the engraftment of lymphocytes into thymus, lymph nodes and spleens. Human T cells (HLA-ABC+/CD3+) increased in lympoid organs as did B lymphocytes. The engrafted cells responded to PHA, produced IFN gamma and IL-2 had natural killer activity, responded to LPS and produced IgG and IgM [87] .
Mice were given lethal total body irradiation followed with a congeneic or syngeneic bone marrow transplantation (BMT). Some groups then received recombinant human PRL (rhPRL). PRL increased thymic cellularity and donor T-cell reconstitution after congeneic BMT. Increases in B cells and myeloid progenitors were also observed. Mitogenic responses by both T and B cells were observed after PRL treatment [88] .
Prolactin Analogs, Agonists, and Antagonists
Male Sprague Dawley rat pups (n = 104) were randomized at birth to receive oil or estradiol benzoate on postnatal days 1, 3, and 5. They were further randomized to receive bromocriptine (BrC) pellets or placebo at d 15. Animals receiving BrC had significantly lower PRL levels at d 90, regardless of estrogen status. Splenic and thymus weights were greater in estrogenized animals, and this was partially reversed with BrC. Neonatal estrogen exposure resulted in a marked infiltration of CD4+ and CD8a+ lymphocytes in the prostate gland, and this was partially reversed by concomitant BrC treatment. In contrast, the estrogen-induced macrophage infiltration of the prostate was not affected by PRL suppression [89] . Elevated PRL (hyperprolactinemia) levels do not lead to an "overstimulation" of the B-cells, but deteriorate the cytotoxic function [90] .
Metoclopramide (MCP) restores the depressed cellular immune function after hemorrhage by increasing the release of the immunomodulatory pituitary hormone prolactin. MCP modulated splenocyte apoptosis and cytokine release in a murine model of sepsis without an impact on the survival [91] . In adult Wistar male rats moderate alcohol consumption may change the regulatory mechanism of prolactin secretion [92] .
Rat PRL cDNA, fused to the cytomegalovirus promoter was injected into mouse muscle. Prolactin mRNA and protein were detected in the muscle following injection. White blood cells (WBC) increased. After adrenalectomy there was an even greater increase. Marked angiogenesis was found in the testis. Direct intramuscular injection of naked DNA can be used effectively to study the function of secreted proteins, including endocrine signaling molecules [93] .
ESTROGENS
Estrogen Receptors [94-96]
The expression of ERalpha and ERbeta was determined in human monocytes and macrophages. N-terminal truncated ERalpha variant, ERalpha46, is expressed in both cell types. Transcription of ERalpha in both cell types occurs from upstream promoters E and F. Treatment with E2 induces ERalpha expression in macrophages but has no effect on ERbeta levels in either cell type. During monocyte-to-macrophage differentiation, ERalpha is upregulated in a time-dependent manner. E2 treatment attenuates production of the chemokine CXCL8 in an ER-dependent manner. ERalpha expression levels parallel the ability of E2 to suppress CXCL8 production [97] . Both ERalpha and beta ERbeta proteins are expressed in nuclei, but not in the cytoplasm of PBMNC harvested from all of the 15 healthy male and female volunteers (aged 23-50 years) tested. PBMNCs contained mRNA coding for the two major full-length isoforms of ERbeta and the expression of ERbeta protein was localized within a lymphocyte subpopulation [98] .
On human macrophages membrane associated ER-alpha participates in E2 induced Bcl-2 increase through activation of the MAP-kinase pathway while cytosolic ER-beta transmits signals for the pro-apoptotic event of Bax translocation. The mechanistic basis of Bax translocation comprised of ERbeta mediated increase in intracellular pH facilitated by activation of the Na(+)-H(+) exchanger. siRNA mediated downregulation of ER-alpha during E2 exposure leads to inhibition of Bcl-2 increase and consequently apoptosis due to the unopposed action of mitochondrial Bax [99] . The membrane estrogen receptors (mERs) studied are involved in estrogeninduced release of prolactin. Membrane glucocorticoid receptors (mGRs) in both mouse and human lymphoma cells are necessary for the initiation of glucocorticoid-induced therapeutic apoptosis which is related to the developmental phenomenon of thymic involution. Diseases of autoimmunity such as systemic lupus erythematosus and arthritis are related to estrogen status. Since both of these mSRs have recently been found in both normal and cancerous lymphoid cells, actions of these mSRs may have important consequences for functions and diseases of the immune system [100] .
Murine dendritic cells and thioglycollate-elicited peritoneal macrophages (PM) express mRNA for ERalpha but not ERbeta. ERalpha-deficient PM exposed ex vivo to lipopolysaccharide or Mycobacterium avium showed significant increases in tumor TNF-alpha secretion and reduction in bacterial load when compared with wild-type PM [101] .
B cells express neither membrane receptors for testosterone (mAR) nor mER on their surfaces, in contrast to other major cells of the immune system such as T cells and macrophages [102] . ERalpha and ERbeta are expressed in murine NK cells. 17beta-estradiol elicited a significant decrease in NK cell activity in both wild-type and ERalphaKO mice (P < 0.001) [103] .
ERs are differentially expressed in PBMC subsets. CD4+ T cells express relatively high levels of ERalpha mRNA compared with ERbeta, whereas B cells express high levels of ERbeta mRNA but low levels of ERalpha. Peripheral blood CD8+ T cells and monocytes express low but comparable levels of both ERs [104] .
Estrogen receptor protein is present in bovine neutrophils. Estrogen receptor beta was expressed, whereas for the estrogen receptor alpha was not found. Both subtypes were found at the mRNA level [105] .
In ERalpha-or ERbeta-deficient mice, the role of ER isotypes in DC differentiation and acquisition of effector functions was studied. Estrogen-dependent activation of ERalpha, but not ERbeta, is required for normal DC development from BM precursors cultured with GM-CSF. Reduced numbers of DCs were generated in the absence of ERalpha activation. ERalpha-deficient DCs were phenotypically and functionally distinct from wild-type DCs generated in the presence of estrogens. In response to microbial components, ERalpha-deficient DCs failed to up-regulate MHC class II and CD86 molecules, which could account for their reduced capacity to prime naive CD4(+) T lymphocytes. Although they retained the ability to express CD40 and to produce proinflammatory cytokines (e.g., IL-12, IL-6) upon TLR engagement, ERalpha-deficient DCs were defective in their ability to secrete such cytokines in response to CD40-CD40L interactions [106] .
Microglia, isolated from adult fms-EGFP mice, express GR, MR, and ERalpha. GR was the most abundant steroid hormone receptor transcript in microglia. After inflammatory challenge a significant down-regulation of GR, MR, and ERalpha was found in microglia. Estradiol benzoate did not have any significant impact on the inflammatory profile of ex vivo sorted microglia. Corticosterone was a more consistent anti-inflammatory agent than 17beta-estradiol in vitro. [107] .
Four types of cross-talk mechanisms were recognized on different cells in which steroids have major roles: (1) TNF potentiates the transactivation activity of GR and the priming with TNF increases the protective action of GR on TNFinduced cytotoxicity. (2) cAMP inhibits the TCR-induced apoptosis through a PKA-CREB-dependent mechanism and potentiates glucocorticoid-induced apoptosis by means of a CREB-independent mechanism. (3) Glucocorticoids inhibit the induction of GATA-3 and T-bet transcription factors. (4) Physical and functional interactions between Smad-4 and estrogen receptors take place in prolactinoma cells, providing a molecular explanation to link the tumorigenic action of these two important players of prolactinoma pathogenesis [108] .
Regulation of T-bet expression was modulated by cytokines, estrogen, and progesterone. Endometrial epithelial cells (EECs) respond to these hormones, singly or in combination, suppressed T-bet production. Stat1 and Stat5 bound to the EEC T-bet regulatory region (TRR) at the IFNgamma-activated sequence site, but Stat3 and Stat4 did not. Binding of Stat1 and Stat5 to the TRR were modified by progesterone in distinct ways. Estrogen suppressed the binding of Stat1 and Stat5 to the TRR. Mutation of gammaactivated sequence element reduced T-bet promoter activity, binding of Stat proteins to the TRR and regulation of the promoter by cytokines and hormones. In EECs, cytokine exposure caused phosphorylation of Janus kinase 2 and TRR-bound Stat proteins; female steroid hormones altered only phosphorylation of TRR-bound Stat5 [109] .
Estrogen treatment had differential effects on NF-kappaB family members. Estrogen profoundly blocked the nuclear translocation of p65, c-Rel, and Rel-B, partially blocked p52, but permitted translocation of p50. Despite blockade of both the classical (p65/p50) and alternative (RelB/p52) NFkappaB activation pathways, estrogen induced constitutive NF-kappaB activity and increased the levels of cytokines regulated by NF-kappaB (IL-1 alpha, IL-1 beta, IL-10, and IFN-gamma). Studies involving a NF-kappaB inhibitor confirmed a positive regulatory role of NF-kappaB on these cytokines. Remarkably, estrogen selectively induced B cell lymphoma 3 (Bcl-3), which is known to associate with p50 to confer transactivation capabilities, thereby providing a potential link between observed p50 DNA-binding activity and estrogen up-regulation of NF-kappaB transcriptional activity [110] .
A selective agonist of ER beta, ERB-041 has a dramatic beneficial effect in the HLA-B27 transgenic rat model of inflammatory bowel disease and the Lewis rat adjuvantinduced arthritis model. Daily oral doses as low as 1 mg/kg reverse the chronic diarrhea of HLA-B27 transgenic rats and dramatically improve histological disease scores in the colon. The same dosing regimen in the therapeutic adjuvantinduced arthritis model reduces joint scores from 12 (maximal inflammation) to 1 over a period of 10 d. Synovitis and Mankin (articular cartilage) histological scores are also significantly lowered (50-75%) [111] . Estradiol fulfils a proinflammatory role, which is probably dependent on conversion to a proinflammatory cocktail of downstream estrogens and the presence of cortisol [112] .
Estrogen treatment increased FasL expression in monocytes through the binding of the ER to the estrogen recognizing elements and AP-1 motifs present at the FasL promoter. Estrogen induced apoptosis in monocytes expressing ERbeta, but not ERalpha. The expression of either ERalpha or ERbeta and their response to estrogen in monocytes was found to be dependent on their stage of cell differentiation [113] .
Estrogen suppresses IL-2 production from activated peripheral blood T cells and CD4+ T cell lines at the transcriptional level. Suppression of IL-2 occurred at short term, high 17-beta-estradiol concentrations as well as longer term lower 17-beta-estradiol concentrations. In CD4+ Jurkat T cells, suppression of IL-2 was associated with decreased nuclear binding of two important IL-2 promoter transcription factors: NFkappaB and AP-1. The decreased nuclear binding of NFkappaB occurred in the setting of estrogen-induced increases in IkappaBalpha protein levels, an important inhibitor of NFkappaB nuclear translocation. 17-beta-Estradiol was also shown to inhibit IL-2 receptor (IL-2R) expression in activated peripheral blood T cells [114] .
Estrogen significantly increased IFN-gamma and IL-2 mRNA in concanavalin-A (Con-A) activated thymocytes, splenic lymphocytes, and in enriched splenic T cells from normal C57BL/6 orchiectomized mice. While estrogen increased IFN-gamma mRNA in Con-A activated unseparated splenic lymphocytes and enriched splenic T cells, a numerical increase in IFN-gamma was noticed only in the supernatants of Con-A activated unseparated splenic lymphocytes, but not in enriched splenic T cells. Con-A activated splenic lymphocytes from gonadal-intact, untreated females had a pattern of numerical increase in IFN-gamma mRNA, and IFN-gamma and IL-2 protein levels compared to their male counterparts [115] .
Estrogen administration promotes strong antigen-specific Th1 cell responses in a mechanism that requires functional expression of ERalpha in hematopoietic cells [116] .
The effects of E2 and 4-estren-3alpha,17beta-diol (estren) on T lymphopoiesis and T cell-dependent inflammation was compared. ER knock-out mice lacking both ERalpha and ERbeta were used. The presence of ERs was mandatory for all the effects of E2. In contrast, treatment with estren reduced thymus cellularity in ER knock-out mice, indicating an effect through ER-independent pathways. Estren suppressed DTH, the frequency of CD4(+) T cells in spleen and serum levels of IL-6 only in wild-type mice, but not in mice lacking ERs [117] . E2-induced downregulation of B lymphopoietic cells in bone marrow of young ovariectomized mice can be mediated through both ER-alpha and ER-beta. However, only ER-alpha is required for the agerelated increased frequency of IgM spot forming cells (SFC) in the bone marrow, as well as for the increased production of interleukin-10 (IL-10) from cultured splenocytes in aged mice. Furthermore, increased age in normal mice resulted in lower levels of both pro-and pre-B cells but increased frequency of IgM SFC in the bone marrow, as well as increased frequency of both IgM and IgA SFC in the spleen [118] .
The expression of ER-beta but not ER-alpha mRNA was found in hairless mouse skin, whereas ER-alpha and ER-beta mRNA were present in normal haired mouse skin. In mice with a null mutation for ER-beta, there was a significant exacerbation of the solar simulated UV (290-400 nm)-induced suppression of contact hypersensitivity. Immunohistochemical analysis revealed that the ER-beta deficiency inhibited the normally immunoprotective upregulation by the UVA (320-400 nm) waveband of the epidermal expression of the cytokines IFN-gamma and IL-12. ER-beta deficiency also significantly increased the UVB-induced expression of the immunosuppressive cytokine IL-10 [119] .
The ERalpha level in splenic murine macrophages on 0.5 day after mating was higher than that in splenic macrophages of pseudopregnant mice on 0.5 day after stimulation. The ERalpha level was also higher in mature than in immature macrophages present in both the spleen and uterus, especially in mated mice. In the spleen, a correlation was found between the percentage of mature macrophages and ERalpha level in these cells [120] .
A single injection of 17beta-estradiol administered to 4-day-old male and female mice increased the cellular immune response, and induced resistance to Taenia crassiceps cysticercosis and changed the expression of progesterone (PR) and ER in the brain and splenocytes. When treated mice reached adulthood, they were highly resistant to infection. Female mice presented early vaginal opening and altered estrous cycles. In mice of both sexes, the expression of PR and ER in brain was differentially regulated after neonatal exposure to estradiol. An increase in the expression of IL-4 and IFN-gamma was found in the serum of experimentally infected neonatally estrogenized animals, which correlated with the observed protection against T. crassiceps infection [121] .
Estrogen and the Central Nervous System (CNS)
A novel estrogen-responsive endogenous N-terminal galanin homologue is present in rat brain [122] . Microglia produce mainly 5-androstene-3beta, 17-beta-diol (Delta(5)-Adiol), a C(19) steroid with estrogen-like activity from DHEA [123] . Hypothalamic sensitivity to peripheral IL-1beta and TNF-alpha may be an important mechanism underlying the sexually dimorphic ACTH response to LPS in rats [124] .
Estrogen and progesterone treatment of ovariectomized rats reduced LPS-induced fever, as compared with ovariectomized controls. This was accompanied by reduced levels of the inducible cyclooxygenase-2 (COX-2) protein expression in the hypothalamus and of IL-1beta. LPS-induced plasma IL-6 was not affected. IL-1 beta induced hypothalamic COX-2 expression potentiated by the ovarian hormone replacement and moderately increased IL-6, which was suppressed by ovarian hormone replacement [125] .
Estrogen's anti-inflammatory effects may be mediated by the pan-neurotrophin receptor p75NTR. In cells associated with microvessels p175NTR expression is dependent on estrogen. This suggests that the blood brain barrier is a critical locus of estrogen's neuro-immune effects [126] .
The gender differences in the HPA response to endotoxin and IL-1 are enhanced by castration and attenuated by androgen and estrogen replacement. Estrogens attenuate the endotoxin-induced stimulation of IL-6, TNF-alpha and IL1ra release in postmenopausal women. There is relationship between the HPA-axis response to endotoxin and nitric oxide formation in the neuro-endocrine hypothalamus, indicating a stimulatory role for nitric oxide in modulating the HPA response to immune challenges [127] .
Inbred female Fischer (F344/N) and Lewis (LEW/N) rats have similar oestrogen levels, although Fischer rats exhibit hyper-and Lewis rats hypo-HPA axis responses. The blunted HPA axis response of Lewis rats is due to their blunted hypothalamic CRH response. Fischer rats responded significantly higher than did Lewis rats. ERalpha and beta mRNA and protein levels in Fischer rats were reduced after LPS administration at the time of maximal CRH mRNA levels but there was no change in Lewis rats, an effect independent of oestrogen levels [128] .
The interaction of E2 with ERalpha plays a critical role in the control of cytokines that regulate the transfer from the innate to adaptive immunity. In mice lacking E2, pathogens hide from immune surveillance and exacerbate neuronal damages during viral encephalitis [129] .
Female prairie voles are induced into estrus by chemosensory stimuli present in conspecific male urine. Prior to estrus induction, female voles have undetectable concentrations of estrogen that rise rapidly following exposure to male animal or male urine. Estrus had increased the numbers of mast cells in the main olfactory bulbs and epithalamus (medial habenula), but not the thalamus or median eminence, relative to control groups [130] .
The apolipoprotein E4 (APOE4) gene is a well-known risk factor for Alzheimer's disease (AD) and other neurological disorders. The anti-inflammatory activity of 17beta-estradiol is significantly reduced in APOE4 targeted replacement mice compared to APOE3 mice. The APOE genotype interacts with 17beta-estradiol for NO and cytokine production by immune activated microglia. Peritoneal macrophages from APOE4 ovariectomized mice also responded to 17beta-estradiol. ERbeta protein in APOE4 microglia was higher than in APOE3 microglia [131] .
Blood Brain Barrier (BBB) [132]
Estrogen and Endothelium
Both testosterone and 17 beta-estradiol increase TNFalpha-induced expression of E-selectin and VCAM-1 in endothelial cells [133] .
Estrogens and Thymus
A higher frequency of CD4+ CD8+ thymocytes was found in ER-alpha(-) mice compared with ER-alpha(+) mice. Female oophorectomized ER-beta knockout mice given E2 displayed a similar thymic atrophy compared with the wildtype strain but thymus cortex involution was limited and thymic CD4/CD8 was not altered. Expression of ER-alpha, but not ER-beta, is mandatory in males for development of thymus and spleen, whereas expression of ER-beta is required for E2-mediated thymic cortex atrophy and thymocyte phenotype shift in female [134] .
Estrogen Effects on Lymphoid Cells [135]
Mouse microglia expressed mRNA for 17beta-hydroxysteroid dehydrogenase type 1 and steroid 5alpha-reductase type 1. Microglia also expressed the peripheral benzodiazepine receptor and steroid acute regulatory protein; however, the enzymes required for de novo formation of progesterone and DHEA from cholesterol were not expressed. Microglia preferentially produced delta-5 androgens (Adiol) from DHEA and 5alpha-reduced androgens from adiol. Adiol behaved as an effective estrogen receptor agonist in neuronal cells [136] .
Estrogen cell surface receptors exist on human monocytes, granulocytes and vascular endothelial cells and are coupled to constitutive nitric oxide synthase derived nitric oxide release via the stimulation of intracellular calcium transients. This cascade down regulates both immune and vascular cellular processes, i.e. adherence [137] . E2 could exacerbate plasmacytoid dendritic cells (PDCs) activation with CpG, which further activates B cells to upregulate susceptibility to autoantigens. IFN-alpha plays an important role in the stimulatory effect of PDCs on B cells. E2 stimulation of IFN-alpha production may result in female prevalence in autoimmune diseases such as SLE through activation of PDCs [138] . Monocyte-derived dendritic cells (mDCs) were cultured in vitro with progesterone and estradiol. The life cycle of mDCs was enhanced, maturation and apoptosis was increased, IL-10 and IL-27 were increased but only Pg increased the production of IL-13 and down regulated the secretion of IL-23 [139] . T cell stimulants (Con-A or anti-CD3 antibodies) release nitric oxide from splenocytes of estrogentreated but not placebo-treated mice. Low dose of T cell stimulants induced NO in splenocytes from estrogen-treated mice, and up-regulated iNOS mRNA, iNOS protein, and cyclooxygenase-2 (a nitric oxide-regulated downstream proinflammatory protein). Blocking CD28 and B7 molecules by CTLA-4Ig markedly decreased IFNgamma and nitric oxide. E2 treatment of IFNgamma-knockout (IFNgamma(-)/ (-)) mice did not induce iNOS protein or NO. Recombinant IFNgamma to Con-A-activated splenocytes from IFNgamma ((-)/(-)) mice induced iNOS protein primarily in estrogentreated mice [140] .
Oestrogen increases the frequency of IgA-producing B cells in muMT-/-mice in both bone marrow and spleen cells [141] .
E2 increased the number of NK cells, but reduced their cytotoxicity. NK cells up-regulated the expression of MCM7 and MCM10 proteins, which are required for DNA replication and cell proliferation and down-regulated the activating receptors-CD69, NKp46, NKG2DL and 2B4 (CD244), which directly inhibited NK cell activation, and reduced the secretion of the soluble factors-granzyme B and FasL [142] .
Monocyte-derived tissue factor (TF) expression can activate the coagulation system and worsen the course of severe infection. Treatment with E2 did not alter resting monocytic cells. However, E2-treated monocytes responded to LPS by increased TF expression and decreased TNFalpha [143] .
17beta-estradiol attenuates LPS-induced expression of CXCL8 in human peripheral blood monocytes. Treatment of monocytes with estradiol before administration of LPS reduces CXCL8 message and protein production through an estrogen receptor-dependent mechanism, which is mediated transcriptionally. Estradiol-pretreated LPS-activated monocytes are impaired in mobilizing neutrophils [144] .
E2 is capable of augmenting FoxP3 expression both in vitro and in vivo. Treatment of naive mice with E2 increased both CD25(+) cell number and FoxP3 expression level. The ability of E2 to protect against autoimmune disease is correlated with its ability to up-regulate FoxP3. E2 treatment and pregnancy induced FoxP3 protein expression to a similar degree [145] .
Estriol significantly inhibited T cell transmigration at a concentration range typical of pregnancy, which correlated with decreased T cell expression of matrix metalloproteinase-9. Estriol altered the cytokine profile of T cells toward Th2 phenotype by up-regulating the production of IL-10 and inhibiting TNFalpha secretion of T cells. The inhibitory effect of estriol on T cells was not antigen-dependent. Estriol inhibited nuclear transcription factor kappa B [146] .
Estrogens and Cytokines
IRF-1 expression is markedly downregulated in splenocytes or purified T-cells from estrogen-treated mice. This decrease in IRF-1 in splenocytes is not due to upregulation of IRF-1-interfering proteins or to alternatively spliced IRF-1 mRNA. Diminished IFN-gamma induction of IRF-1 in cells from estrogen-treated mice was noticed despite comparable phosphorylated STAT-1 activation [147] .
Plasmacytoid dendritic cells release IFN-alpha upon TLR7 and TLR9 ligation. Human blood was incubated with synthetic TLR7 and TLR9 ligands. Female PBLs produced significantly higher IFN-alpha levels after TLR7 stimulation compared with male PBLs. No sex differences were evident after TLR9 stimulation [148] .
MicroRNAs (miRNAs), recently identified noncoding small RNAs, are emerging as key regulators in homeostasis of the immune system. Therefore, aberrant expression of miRNAs may be linked to immune dysfunction, such as in chronic inflammation and autoimmunity. miR-146a, a negative regulator of TLR signaling, was decreased in freshly isolated splenic lymphocytes from estrogen-treated mice compared with placebo controls. Increasing the activity of miR-146a significantly inhibited LPS-induced IFNgamma and iNOS expression in mouse splenic lymphocytes. The expression of miRNAs in mouse splenic lymphocytes is selectively up-regulated and down-regulated by estrogen. miR-223, which is markedly enhanced by estrogen, regulates LPS-induced IFNgamma, but not iNOS or nitric oxide in splenic lymphocytes. Inhibition of miR-223 activity decreased LPS-induced IFNgamma in splenic lymphocytes from estrogen-treated mice [149] . Con-A-stimulated splenic lymphocytes from orchiectomized or ovariectomized C57BL/6 mice exposed to estrogen for 3-5 months secreted higher levels of IFN-gamma protein compared to controls. This is due to increased levels of IFN-gamma mRNA. Estrogen also increased co-stimulatory CD80 (B7-1) Prenatal mice exposed to DES had a normal ability to secrete IFNgamma. However, a second exposure of these mice to DES led to a pronounced increase in the number of IFN-gamma secreting cells and augmented secretion of IFN-gamma. DES-induced increase in IFN-gamma secretion is due to hormonal effects on T cells but not on APC [150] .
Serum IL-1beta and IL-10 were studied shortly after ovariectomy, before the establishment of overweight in rats. Female Wistar rats were submitted to ovariectomy, ovariec-tomy and estradiol replacement, or sham operation and compared with intact controls. Shortly after ovariectomy (at 3 d) serum interleukin-1beta levels significantly increased in ovariectomized rats, treated or not with estradiol, while serum interleukin-10 levels increased only 9 d after ovariectomy [151] . IL-6 treatment induced an increase in the expression of gp130 and JAK1 by hybridoma B cells. E2 and P4 diminished the IL-6-induced gp130 expression in a dosedependent manner, whereas the expression of JAK1 was not significantly affected. At 10(-6)M concentration, the steroids inhibited the phosphorylation of gp130 and diminished the IL-6-induced STAT3 phosphorylation and translocation to the nucleus. Maximal progesterone-induced blocking factor (PIBF) expression was observed when the hybridoma was cultured with 10(-10)M P4, compared to the control (p<0.05) [152] . E2 treatment of human monocyte-derived immature dendritic cells (iDCs) significantly increased the secretion of interleukin 6 (IL-6) and osteoprotegerin (OPG) by DCs. E2 significantly increased the secretion of IL-8 and MCP-1 by iDCs. After E2 pretreatment the LPS-induced production of MCP-1, TARC, and MDC by DCs was clearly enhanced. Mature DCs pretreated with E2 stimulated T cells better than did untreated DCs. E2 provides an essential signal for migration of mature DCs toward CCL19/macrophage inflammatory protein 3beta (MIP3beta) [153] . Estrogen may suppress lymphocyte mitogenesis through ERalpha in B and T cells [154] .
Estrogens and Immune Function [155-161]
During a healthy immune response, activation-induced deaminase (AID) deaminates cytosines at Ig loci, initiating somatic hypermutation (SHM) and class switch recombination (CSR). Protein levels of nuclear AID are tightly controlled, as unregulated expression can lead to alterations in the immune response. Furthermore, hyperactivation of AID outside the immune system leads to oncogenesis. The estrogen-estrogen receptor complex binds to the AID promoter, enhancing AID messenger RNA expression, leading to a direct increase in AID protein production and alterations in SHM and CSR at the Ig locus. Enhanced translocations of the c-myc oncogene showed that the genotoxicity of estrogen via AID production was not limited to the Ig locus. In breast and ovaries estrogen induced AID expression by >20-fold. The estrogen response was also partially conserved within the DNA deaminase family (APOBEC3B, -3F, and -3G), and could be inhibited by tamoxifen, an estrogen antagonist. We therefore suggest that estrogen-induced autoimmunity and oncogenesis may arise through AID-dependent DNA instability [162] . In ovariectomized adult Balbc mice there were no differential effects on peripheral immune functions between cyclic and sustained estrogen administration under the same total dose [163] .
17-beta estradiol treatment in outbred mice, at relatively modest doses (2-4 microg/100 g body weight), affected both thymocytes and splenocytes. This treatment did not cause robust changes in the male reproductive system (testicular and seminal vesical weights to body weight ratios) [164] . Physiological doses of E2 to mice expanded Treg cells in different tissues and also increased the expression of the Foxp3 gene, a hallmark for CD4+CD25+ Treg cell function, and the IL-10 gene as well. ER are expressed by CD4+CD25-T cells and the conversion of CD4+CD25-T cells into CD4+CD25+ T cells by E2 could be inhibited by ICI182,780, a specific inhibitor of ER(s) [165] . E2, at a higher than physiological concentration, increased the activity of NF-kappaB in Jurkat cells stimulated by PMA/ionomycin or TNF-alpha. These effects were mediated through ERbeta. Both ERalpha and ERbeta are directly associated with NF-kappaB in the cell nucleus. Considering that NF-kappaB regulates the expression of various genes essential for cell growth and death, estrogen could regulate the fate of T cells by affecting the activity of NF-kappaB. E2 increased apoptosis of Jurkat cells and decreased that of human peripheral blood T cells [166] .
Physiological doses of oestradiol (E2) found during pregnancy, combined with activation through CD3/CD28 engagement, promoted the proliferation of Treg cells without altering their suppressive phenotype. Enhanced suppression was detected when Treg cells were pretreated with the hormone as well as when both cell subpopulations (Treg and T effector) were exposed to E2 [167] . Supraphysiological levels of estrogen in vivo induce damage in lymphoid cells [168] . Estrogen promotes a DC population with the unique features of epidermal Langerhans cells and differentiation of Langerhans cells in vivo is dependent upon local estrogen levels and ER-mediated signaling events in skin [169] . Lewis rats were immunized with inoculum containing MBP (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) . DCs from spleen monocytes of EAE rats were treated with IL-4 and GM-CSF in presence of 17 betaestradiol. E2 activated DCs by accelerating the maturation process characterized by upregulation of MHC II and costimulating molecule B7-1, B7-2, drastic high expression of CD40. IFN-kappa-producing DCs were also elevated without any alteration of IL-10. Estradiol-treated DCs (E2-DCs) secreted more NO in the culture supernatant. By contrast, E2-DCs showed decreased antigen presentation ability with reduced secretion of IFN-kappa but no alteration of IL-10 in the coculture with T cells [170] .
Mouse spleen dendritic cells (SDCs) were treated with E2. E2 reduced the proliferation, stimulative capacity of SDCs and increased endocytosis by SDCs in a dosedependent pattern. E2 up-regulated IL-10 mRNA levels in SDCs in a dose-dependent manner except for the 24 h time point [171] . CD11c-positive murine SDCs were treated with various concentrations of E2 for 24h. E2 increased the viability and MHC-II expression but decreased nuclear NFkappaBp65 level and endocytosis of SDCs. E2 also increased the stimulatory capacity of SDCs from low-dose group but decreased it from middle-and high-dose ones. In addition, E2 increased the intracellular expression of IL-6 and IL-10 in SDCs, but no obvious change appeared in IL-12 and TNF-alpha [172] .
DC from Lewis rats with EAE were studied. Estrogen did not affect the expression of MHC class II, CD80 and CD86 by DC, but inhibited the ability of DC to stimulate T cell proliferation and production of both Th1 and Th2 cytokines. This was accompanied by increased T cell apoptosis. Estrogen up-regulated DC to express indoleamine 2,3-dioxygenase (IDO) which can limit T cell responses. The effects of estrogen-exposed DC on T cell proliferation and apoptosis were partly abolished by addition of an IDO inhibitor (1-methyl-dl-tryptophan, 1-MT), indicating that estrogen-exposed DC induced IDO-dependent T cell suppression [173] .
The cultured human monocytic/macrophage cell line (THP-1) was activated with IFN-gamma and cultured in the presence of E2 and testosterone (final concentration, 10 nM). Androgens increased apoptosis, and oestrogens showed a protective trend on cell death, both acting as modulators of the NF-kappaB complex [174] . E2 activated a delayed phase of Ca(2+) influx involving L-type channel and regulated macrophage immune redox function [175] .
After stimulation by PMA, the human myeloid monocytic THP-1 cells showed the presence of ER, together with markers of monocytic cell differentiation such as CD68, CD54 and HLA-DR [176] . Glucocorticoids, sex steroids, and dopaminergic drugs modulate macrophage FcgammaR expression. Estradiol increases macrophage FcgammaR expression. In guinea pigs six estrogens have been studied: ethynylestradiol (Et), mestranol (M), chlortianisene (Ct), promestriene, 17-epiestriol, and 17beta-estradiol. Estrogens enhance the clearance of IgG-sensitized erythrocytes by increasing splenic-macrophage FcgammaR expression. Et, M, and Ct were more effective than the other estrogens. Estrogens increase the cell surface expression of FcgammaR1 more than that of FcgammaR2 [177] .
Estrogens influence invariant natural killer T cells, which leads to gender dimorphism in IFN-gamma production profile [178] .
Estradiol increased spleen endothelial cell estrogen receptor (ER) alpha 2.9-fold and decreased estrogen receptor beta 2.1-fold while decreasing both receptors on dermal cells. Estradiol enhanced adhesion of D10 cells to spleen but not dermal endothelial cells, an increase that was inhibited by antibodies to VCAM-1 and ICAM-1, and by the estrogen receptor antagonists tamoxifen and ICI 182,780. Estradiol induced greater VCAM-1 expression on spleen than dermal endothelial cells (P < 0.05). Estrogen specifically and preferentially promoted spleen chemokine protein expression for MCP-1 and MCP-3, while having no effect on dermal protein expression for these chemokines. Estradiol-mediated effects on splenic chemokines were abrogated by tamoxifen and ICI 182,780 [179] . Testosterone and E2 increase TNFalpha-induced expression of E-selectin and VCAM-1 in endothelial cells [180] .
Microarray gene expression was used for profiling of rat peripheral blood leukocytes subjected to in vivo treatment by estradiol, the selective ERalpha agonist 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), and the selective ERbeta agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN). It was demonstrated that peripheral blood leukocytes are responsive to estrogens. E2 and selective ERalpha and ERbeta agonists regulate a number of genes that may contribute to inflammation and remodeling of the extracellular matrix [181] .
The effects of single injections of estradiol into the yolk were investigated at day 4 of incubation on the development of the bursa and spleen as indices of treatment effects on the immune system. Follicle size and numbers in hatchling bursas were significantly reduced. Distorted plicae and thicker epithelial layers surrounding the plicae were observed in day-old chicks. Adult bursas from birds embryonically exposed to estrogen were significantly larger than controls [182] .
The changes in B cell Ig secretory activity in the tissues of female rhesus macaques during the menstrual cycle is due apparently to the action of ovarian steroid hormones on CD8+ T cells [183] . Female subjects have a nearly 30% lower innate immune response to LPS, which was largely independent of the HLA-region TNF locus and plasma estrogen level [184] .
Estrogens exert a dual effect on the immune system: (1) inhibition of cell-mediated immunity through a reduction of interleukin-2 receptors; (2) increased proliferative response to interleukin-2 [185] .
Estrogen and testosterone inhibited T cell line proliferation, induced accumulation of cells in S/G(2)M phases of the cell cycle, and increased apoptosis. Estrogen and testosterone were not inhibitory to B cell lines. In comparison, progesterone induced cytostasis and modestly increased apoptosis in both T and B cell lines. Progesterone antagonized cell cycle and apoptotic effects of estrogen in T cells. Estrogeninduced cell cycle and apoptotic effects in T cell lines were associated with suppression of bcl-2 protein levels, which were unaffected in Raji B cells. Progesterone also antagonized the estrogen-induced changes in T cell bcl-2 protein levels [186] . Splenic adherent cells from C57BL/6N mice were stimulated by E2 and up-regulated IgM production of lymphocytes through direct cell-cell interactions. The enhancing effect of E2 arouse through ERalpha and ERbeta on these cells [187] .
Several genes involved in B cell activation and survival, including cd22, hp-1, bcl-2, and vcam-1, were upregulated by estrogen in B cells. Overexpression of CD22 and SHP-1 in B cells decreased B cell receptor signaling. Estrogen receptors alpha and beta are expressed on B cells upregulate expression of CD22, SHP-1, and Bcl-2. Estrogen treatment protected primary B cells from B cell receptor-mediated apoptosis [188] .
CD45(dim)VLA-4(+) cells, may play a role in the protective effects of estrogen in EAE. Injection of purified CD45(dim)VLA-4(+) cells conferred protection from spontaneous EAE (Sp-EAE). In contrast, injection of CD45(high)VLA-4(+) cells exacerbated the disease course. CD45(dim)VLA-4(+) cells also suppressed antigen-specific proliferation of primed lymphocytes in coculture [189] .
E2 attenuates H3 and H4 histone acetylation and cAMP response element binding protein-binding protein association with the class II MHC promoter, suggesting that E2 inhibits class II MHC expression by a novel mechanism involving modification of the histone acetylation status of the class II MHC promoter [190] .
ERalpha deficiency in splenic macrophages enhanced the proliferative response and IFN gamma production by antigen specific CD4+ T cells. When E2 was added, IL-4 and GATA-3 mRNA production were increase in normal, but not in ER-alpha deficient CD4+ T cells [191] . ER, especially ERbeta, plays a key role in mediating the modulation of immune response by estrogen. ERbeta disruption may increase the sensibility towards autoimmune diseases [192] .
The effects of E2 were investigated on endotoxin susceptibility in mice. Importantly, we have examined the actions of this female reproductive hormone on the expression of pattern recognition receptors that recognize bacterial endotoxin by key innate immune cells. The removal of endogenous estrogens decreases both pro-and antiinflammatory cytokine production, with a concomitant reduction in circulating levels of LPS-binding protein and cell surface expression of Toll-like receptor 4 on murine macrophages. Exogenous in vivo replacement of E2, but not progesterone, significantly elevates sera LPS-binding protein levels and cell surface expression of Toll-like receptor 4 and CD14 on macrophages. Furthermore, this effect corresponds with significantly higher inflammatory cytokine levels after in vivo lipopolysaccharide challenge and a marked increase in endotoxin-associated morbidity [193] . In female BALB/c mice estriol (E3) had a very different effect than E2 on the antigen-induced production of specific antibodies in animals immunized with two different antigens, i.e., the bovine serum albumin (BSA) and pneumococca polysaccharide serotype-14 (PPS-14). While E2 strongly stimulated the production of BSA-specific antibodies (mostly IgG1), E3 had little or no effect on their production. In comparison, when the bacterial PPS-14 was the immunogen, E3 and E2 both strongly increased the production of PPS-14-specific antibodies (mostly IgM). E3 and E2 also had a similar effect on the thymus weight reduction and on the spontaneous antibody production in these animals [194] . Lipopolysaccharide alone inhibited cell cycle progression in THP-1 monocytelike cells and U-937 histiocyte-like cells. Estrogen alone produced cell cycle arrest in all myelomonocytic cells except HL-60 pro-myelocyte-like cells. Progesterone had effects predominantly on pro-myelocytic-like HL-60 cells, inducing apoptosis. Estrogen and progesterone both decreased levels of bcl-2 in KG-1alpha, HL-60, and THP-1 cells. LPS partially antagonized both estrogen-induced THP-1 apoptosis and its suppression of bcl-2 protein [195] .
4-estren-3alpha, 17beta-diol (estren) has similar effects as the androgen 5alpha-dihydrotestosterone (DHT) on lymphopoiesis in thymus and bone marrow, and on submandibular glands, and these effects are independent of estrogen receptors. This supports the hypothesis of estren is able to signal through the androgen receptor [196] .
Estrogens and Bone [197-201]
Successful osteoclast formation in vitro requires contact between stromal and hemopoietic cells, leading to the concept of a membrane-associated stromal cell molecule that specifically programs osteoclast differentiation. Once they are formed in the presence of osteoblasts, osteoclasts are active, and hormones or cytokines do not promote the activity of mature osteoclasts, but more likely influence their survival. Of the two best known hormonal inhibitors of bone resorption in vivo, calcitonin acts directly upon osteoclasts to inhibit their activity, whereas estrogen acts indirectly, via the regulation of several cytokines [202] .
Ovariectomized mice had more B-cells and CD3+ T-cells expressing the receptor activator of NF-kappaB ligand (CD3+/RANKL+). The ovariectomized mice had lower serum alkaline phosphatase activity, a normal amount of T cells, lower percentages of CD11b+ and CD51+ cells in the bone marrow, and a lower serum interferon-gamma level compared with sham-operated controls [203] . Ovariectomy (ovx) disregulates T lymphopoiesis and induces bone loss by stimulating, through a rise in IL-7 levels, both thymicdependent differentiation of bone marrow-derived progenitors and thymic-independent, peripheral expansion of mature T cells. Thymectomy decreases by approximately 50% the bone loss and the stimulation of T lymphopoiesis induced by ovx. In contrast, in vivo attenuation of the elevated IL-7 completely prevents the stimulation of T lymphopoiesis and the bone loss that follow ovx [204] .
TNF-alpha knock-out mice (TNF-/-), as well as transgenic mice without thymus (and therefore without mature T cell), do not lose bone after ovariectomy like mice of normal genetic background. The presence of TNF-alpha producing T-cell is essential for estrogen deficiency to influence bone metabolism. Increased IFN-gamma levels result from ovariectomy-induced enhancement of IL-12 and IL-18 secretion by macrophages. IFN-gamma promotes the expression of MHC-II, which makes the macrophages more active in antigen presentation to T-cells, which in turn produce TNF [205] . Increased IFN-gamma-induced class II transactivator expression and the resulting enhanced T cell proliferation and lifespan are critical to the bone wasting effect of estrogen deficiency [206] .
Estrogens and Bone Marrow
In GM-CSF-supplemented cultures initiated from myeloid progenitors (MP), physiological amounts of estradiol promoted differentiation of Langerhans-like DC. Conversely, in Flt3 ligand-supplemented cultures initiated from the same MP, estradiol inhibited cell survival in a dosedependent manner, thereby decreasing the yield of plasmacytoid and conventional myeloid and lymphoid DC. Experiments with bone marrow cells from ER-deficient mice and the ER antagonist ICI182,780 showed that estradiol acted primarily via ERalpha to regulate DC differentiation [207] .
Estrogens and Uterus [208, 209]
Functionally, IL-13 and IL-15 1-100 ng/ml displayed a limited mitogenic activity towards endometrial epithelial (EEC) and stromal (ESC) cells; however, they regulated the expression of TNF receptor type 1 (TNFR) mRNA and soluble protein in a cell-specific manner (P < 0.05) [210] .
Estradiol inhibited the IL-1beta-mediated mRNA expression and secretion of human beta-defensin-2 and CXCL8 by uterine epithelial cells while progesterone had no effect. Inhibition of the IL-1beta-mediated response by estradiol was dose dependent, with maximal inhibition observed using 10(-7) to 10(-10) M, and was shown to be mediated through the estrogen receptor because addition of a pure estrogen receptor antagonist abrogated this effect [211] .
Estrogens and glucocorticoids (dexamethasone) have major, but opposing, effects on the amount and latent activity of complement effectors in the uterus. Treatment with E2 induced vasodilation and an increase in vascular permeability, which resulted in extravasation of plasma and complement into the uterus, rather than de novo complement biosynthesis. That E2 induced a potent bactericidal activity in uterine luminal fluid and that the antibacterial component was complement. These proinflammatory and immunomodulatory effects were evident within 4 h of treatment and were blocked by coadministration of dexamethasone. We also found that estrogen effects on the vasculature were mediated in part by activation of the contact system and bradykinin B1 receptors [212] .
Trophoblasts inhibit T lymphocytes through IDOmediated tryptophan depletion and placenta-derived immunoregulatory factors. The proteins inhibiting T lymphocytes include HCG, HCS, AFP, pregnancy-specific beta 1-glycoprotein (SP1), glycodelin, transforming growth factor beta2, thrombospondin-1, pigment epithelium-derived factor (PEDF). Immunological tolerance at maternal-fetal interface represents a synergistic effect of these substances and a complex mechanism involving endocrine and immune network [213] .
Human chorionic gonadotropin (hCG), a glycoprotein hormone that plays a critical role in the initiation and maintenance of pregnancy, markedly stimulates MIF expression in endometrial stromal cells. Cell treatment with hCG resulted in a dose-dependent increase in MIF protein secretion and mRNA steady-state levels Nuclear transcription assays (run-on) revealed that hCG acts predominantly by upregulating MIF gene transcription [214] .
Estrogens and Ovary [215]
Immunization of SWXJ female mice with the p215-234 peptide derived from mouse inhibin-alpha activates CD4(+) T cells and induces experimental autoimmune oophoritis , which is followed by a delayed stage of premature ovarian failure (POF). Affected mice show inhibin-alpha-neutralizing Abs that prevented inhibin-mediated down-regulation of activin-induced pituitary FSH release. The loss of activin/FSH down-regulation leads to prolonged metestrusdiestrus, superovulation, increased numbers of mature follicles, increased offspring, accelerated depletion of primordial follicles, and ultimately premature infertility [216] .
Passive immunisation against leptin resulted in an acute increase (P < 0.05) in ovarian oestradiol secretion. Conversely, direct ovarian arterial infusion of low dose of leptin resulted in an acute decline (P < 0.05) in ovarian oestradiol secretion whereas the high dose, which resulted in supraphysiological leptin concentrations, had no effect on oestradiol production compared with controls. Leptin had no effect on gonadotrophin concentrations or ovulation but both doses resulted in an increase (P < 0.05) in progesterone concentrations over the subsequent luteal phase [217] .
Together with an increase in progesterone and E2 during the luteal phase, there is an increase in percentage of TNFalpha-and IL-1 beta-producing peripheral monocytes after in vitro stimulation with endotoxin as compared with the follicular phase of the ovarian cycle [218] .
Estrogens and Testis
The presence of melatonin (MLT) receptors, their modulation, and the effect of MLT on steroidogenesis have been studied on Percoll-purified rat Leydig cells (LCs) cultured in vitro. MLT receptors present in adult rat LCs are coupled through a pertussis toxin-sensitive G-protein and are downregulated by prolonged exposure to MLT itself. When acutely added for three hours, MLT (0.4-400 nM) inhibits testosteron (T) secretion in response to LH, forskolin, and GnRH, but sensitizes cAMP-dependent T secretion when present in the preincubation media (16 h). The acute inhibition of adenylyl cyclase and the block of 17-20-desmolase (with increased 17-OH-progesterone) and of calcium release from the intracellular stores, followed by sensitization of the adenylyl cyclase activity, are described as mechanisms of MLT action [219] .
Estrogens and Pregnancy [220, 221]
Pregnancy-associated doses of E2 plus TNF-alpha induce distorted maturation of human DCs that result in an increased capacity to induce T helper (Th) 2 responses. E2 elicited the ability of DC to produce CC chemokine ligand 1, which can attract CCR8-expressing Th2 cells and regulatory T cells. In addition, E2/TNF alpha-matured DCs increased the production of IL-10 relative to the IL-12p70 on CD40 ligation, thereby inducing naive T-cell differentiation into a Th2. Moreover, the increased concentration of E2 in the route of maturation did indeed further enhance Th2 deviation. The dominant Th2 deviation was induced at a high E2 concentration typical during pregnancy [222] .
Inhibition of antiallogeneic responses is restricted both locally to the reproductive tract and temporally to the estrous phase of the menstrual cycle, potentially decreasing the risk of maternal immunization against paternal Ags during insemination [223] .
Exercise
Estrogen-treated, ovarian-intact mice showed less wheelrunning activity than mice implanted with placebo (P<.001). E exposure induced lighter thymuses (P<.05), higher thymocyte apoptosis (P<.001), and higher serum E levels (P<.001), effects which were not modified by voluntary exercise. Splenocyte apoptosis and spleen weights did not differ by estrogen treatment or exercise [224] .
Estrogens and Ageing [155]
In microglia, from the olfactory bulbs of ovx young adult and reproductive senescent animals, LPS increased IL-1beta, but estrogen had no effect. In young adult-derived microglia, LPS also increased nitric oxide (NO), which was attenuated by estrogen, and MMP-9, which was not affected by estrogen [225] .
Embryonic B lymphopoiesis was unaffected by estrogen, but sensitive to glucocorticoids. Only adult precursors efficiently acquire functional estrogen receptors [226] .
Aged man and woman had decreased (CD45(+) cells) expressing GHRH in B cells (CD20(+)) and monocytes (CD14(+)), but not in T cells (CD3(+)
. GHRH mRNA expression in PBMC derived from postmenopausal women was lower than premenopausal women. PBMC from women receiving HRT secreted more GHRH [227] .
In parallel studies, groups of aged mice given E2 prior to scald burn, had significantly improved survival (p<0.05) and lowered serum IL-6 (p<0.05) [228] . Delayed type hypersensitivity (DTH) was completely absent in aged burn-injured mice. Etrogen replacement in aged mice restored the postinjury DTH responses (P < 0.05). This restoration paralleled a recovery in IFN-gamma production by splenocytes, but not IL-4 production [229] .
Estrogen Analogs, Agonists, Antagonists
In human osteosarcoma U2OS cells ERbeta agonists regulate inflammatory genes, such as TNF-alpha, IL-6, and CSF2. Three ERbeta-selective compounds, ERB-041, WAY-202196, and WAY-214156, repressed the expression of these and other inflammatory genes [230] . E2-reduced the clinical severity of EAE. ERalpha ligand treatment was antiinflammatory, ERbeta ligand treatment was not. ERbeta ligand reduced demyelination and prevented neuronal abnormalities in gray matter. ERalpha ligand abrogated the disease ERbeta ligand treatment promoted recovery [231] .
Induction of IFN-related genes in three normal human mammary epithelial cell strains suggests that, in addition to hormonal effects, tamoxifen exposure may enhance immune response in normal breast tissue [232] . Tamoxifen is capable of inducing a shift from cellular (T-helper 1) to humoral (Thelper 2) immunity. The immunomodulatory effects of tamoxifen appear to be independent of the estrogen-receptor [233] . Tamoxifen treatment is a new therapeutic possibility to treat cysticercosis, because it can act at both ends of the host-parasite relationship, i.e., by increasing the cellular immune response protective against the parasite and by directly affecting the parasite's reproduction and survival [234] . Raloxifene and tamoxifen impair E2-promoted DC differentiation and reduce the immunostimulation by DC. SERM may depress immunity when given to healthy individuals for the prevention of osteoporosis and breast cancer and may interfere with immunotherapeutic strategies [235] .
Oophorectomized and sham-operated animals were treated with s.c. injections of equipotent anti-osteoporotic doses of E2 or raloxifene analogue LY117018 (LY). E2 and LY had similar effects on B lymphopoiesis, while LY had antagonized endogenous estrogen in uterine tissue [236] . Fifty-three healthy postmenopausal women were treated by raloxifene RAL, HRT [2 mg estradiol valerate + 2 mg dienogest, continuously] n = 18) or placebo (Group III, n = 19). RAL treatment caused a significant decrease on serum IL-4 concentration (P < 0.001). Serum TGF-beta1 was decreased by HRT [237] . The raloxifene analogue LY117018 can activate the classical oestrogen pathway in bone, uterus and thymus in vivo, and this activation is associated with bone mineral density and uterus weight, but not thymus weight [238] .
Oestrogen may influence B cell function through the oestrogen antagonist, ICI 182,780-sensitive receptors, and ICI 182,780 may have agonist actions on the immune system [239] . Male CD-1 mice were treated topically or subcutaneously with DES (10 and 100 mg/kg.) DES induced a significant time-and dose-dependent reduction in the number of lymphocytes [240] .
Diethylstilbestrol (DES) alters T-cell differentiation in the thymus by interfering with positive and negative selection processes, which in turn modulates the T-cell repertoire in the periphery [241] . Thirteen women exposed to diethylstilbestrol in utero were compared with controls; tritiated thymidine incorporation by T cells from DES-exposed women was increased 3-fold in response to Con A (P <.001), increased by 50% in response to PHA (P <.001), and increased 2-fold in response to Il 2 (P <.05 [243] . Low doses of DES (diet containing 0.4 or 4.0 microg/kg diet) were given for 2 months to young adult and aged C57BL/6 mice, and thymic and splenic parameters were monitored. Low dose of exogenous estrogen are dependent on the age and sex of the recipients and many parameters show nonmonotonous dose response effect [242] .
ERA-63 is a low molecular weight estrogenic pharmaceutical with immunomodulatory effects. After 28 days of treatment with ERA-63 doses (0.167-0.2, 1.67-2 and 16.7-20mg/kg) had estrogenic with comparable activity to respective E2 dose levels (0.05, 0.5 and 5mg/kg) [243] .
The human fetal steroid, estetrol (E4), is a potent, orally bioavailable, natural human fetal selective estrogen receptor modulator, since it acts in the rat as an estrogen. E4 may be a potential drug for human use in hormone replacement therapy (vaginal atrophy, hot flushes), contraception and osteoporosis and others [244] .
Androgens [246-249]
The effects of APOE genotypes on androgen-mediated regulation of inflammation using mice expressing only the human APOE3 or human APOE4 gene were studied. Antiinflammatory activity of DHT is significantly reduced in APOE4 mice compared to APOE3 mice. Innate immunity plays a role [250] .
In humans dehydroepiandrosterone (DHEA) up-regulates the Th1 immune response. Steroid sulphatase is a microsomal enzyme that cleaves the sulphate group of DHEA sulphate. Women's macrophages produce higher levels of DHEA, which produce stronger Th1 immune responses [251] .
Macrophages of NZB\BALBc mice were treated with 5alpha-DHT, which changed protein secretion. Highly specific androgen binding was observed at physiological concentration. High affinity receptors were expressed for 5alpha-DHT [252] .
Bone marrow transplantation using an androgen-resistant mouse strain showed that thymic epithelial cells and bone marrow stromal cells are mediators of androgenic effects on immature lymphocytes [253] .
Hormones and cytokines were measured in seminal plasma of 35 donors. Steroids hormones and cytokines in semen exert locat immunosuppression in the female genital tract [254] .
Androgen Analogs
Endogenous androgens may suppress chemotactic response. Postmenopausal hormone therapy and raloxifene may inhibit the expression of chemoattractant molecules and thus attenuate inflammation [255] .
HE3286 (17alpha-ethynyl-5-androstene-3beta, 7beta, 17beta-triol) is a synthetic derivative of a natural antiinflammatory steroid, beta-AET (5-androstene-3beta, 7beta, 17beta-triol). HE3286 was safe and well tolerated in phase I studies and is under evaluation in multicenter phase I/II clinical trials for ulcerative colitis and arthritis [256] .
Medical castration was done on healthy men by using the GnRH antagonist, acyline. CD4+ CD25+ T cells decreased, mitogen-induced CD8+ T cell IFN-gamma expression, and NK cells increased without affecting the ratio of CD4+ to CD8+ T cells and the NK cell-activating receptor NKG2D or homing receptor CXCR1 [257] .
PROGESTOGENS
Progesterone and Immune Function [258-261]
Recently, three new putative membrane progesterone receptors (mPRs), mPRalpha, mPRbeta, and mPRgamma have been described. These receptors may differentiate CD8 but not CD4 lymphocytes, bind to Jurkat T cells and activate an inhibitory G protein (G(i) [262] .
Progesterone might inhibit innate immune response by suppressing NF-kappaB activation and enhancement of SOCS1 expression, providing a possible mechanistic explanation for the function of progesterone in regulating innate immune responses [263] . Progesterone (P4) is known to induce the suppression of immune responses, particularly during pregnancy. However, knowledge about the mechanisms involved has remained largely elusive [264] . Progesterone rapidly suppresses the fetal inflammatory response, possibly via nongenomic activation of the cAMP cascade [265] . Women present a predominant Th2 cytokine profile, which could be involved in immune responses characterized principally by the secretion of antibodies [266] . The murine microglial cell-line, BV-2, was cultured with LPS to induce NO and examined progesterone and its metabolites, 5alpha-dihydroprogesterone (DHP) and 5alpha-3alpha-tetrahydroprogesterone (THP), on NO release. LPS-induced NO was suppressed by progesterone and THP. NO release was sensitive to N(G)-methyl-L-arginine (L-NMMA) [267] . Differential expression of genes by uterine lumenal epithelium (LE)/ superficial glandular epithelium (sGE), mid-to deepglandular epithelia (GE), and stromal cells in response to progesterone and IFNs is likely to influence uterine receptivity to implantation in most mammals [268] .
During initial stages of granulosa cell apoptosis progesterone production does not decrease. Granzyme B, a protease that normally resides in T cytotoxic lymphocytes and natural killer cells of the immune system is present and activated in granulosa cells [269] .
Male rat peritoneal macrophages were treated with LPS, E2 or progesterone. E2 enhanced TNF release, which was inhibited by E2 and plus progesterone. E2 and progesterone enhanced H2O2 release by LPS-treated macrophages and each inhibited NO2-release by LPS-treated macrophages [270] .
Pregnant mice on day 15 of gestation received intrauterinally (1) saline, (2) LPS, (3) an intramuscular injection of medroxyprogesterone acetate (MPA) prior to LPS, or (4) MPA alone. LPS reduced macrophages and enhanced neutrophils in the cervix which was blocked by MPA Cervical remodeling was induced by LPS, and blocked by MPA reduced innervation in the cervix [271] .
Progesterone directly inhibits mature rat bone marrow DC capacity to drive pro-inflammatory responses [272] . Progesterone promotes the maturation of murine spleen CD11c-positive dendritic cells (SDCs) and enhances their ability to interact with T cells, which changes the course of autoimmune diseases [273] . Progesterone may be involved in the maternal immune response by modulating DC differentiation, maturation and function [274] . PBMC-derived DC seem to be relatively stable against the influence of pregnancy associated hormones apart from particular effects on cytokine production which partly could contribute to the modification of immune responses observed in normal early pregnancy [275] . Blood leukocytes were isolated from human decidua and analyzed for the expression of HLA-DR and CD83 markers. When P4 is added to DCs cultured in vitro the percentage of cells expressing both markers increased in specific and dose-dependent manner [276] . Progesterone promotes the production of IL-4 and IL-5, whereas relaxin promotes the production of IFN-gamma by T cells. LIF is up-regulated by IL-4 and P4. The production of LIF and/or Th2 cytokines by decidual T cells contributes to the maintenance of pregnancy [277] .
Cytotoxic lymphocytes, which are responsible for firstline immune defense, and B cells, which are involved in autoimmune disorders, are affected by oral contraception (OC; Cileste, 250 microg of norgestimat and 35 microg of ethinylestradiol, or Marvelon, 150 microg of desogestrel and 30 microg of ethinylestradiol) [278] .
Hybridoma 112D5 B cells expressed both E2 and P4-receptors (ER and PR). At 48 hr, P4and E2 slightly decreased cell proliferation whereas IL-6 did not. IL-6, 10(-10) M P4 but not E2 induced asymmetric antibody production. P4 at 10(-6) M decreased antibody synthesis by hybridoma cells. P4 and E2 increased IL-6 synthesis [279] .
Oestrogen, P4 and DHEA-S and the number of human blood cells secreting IL-2, IL-4, IL-6, IL-10, tumour TNFalpha or IFN-gamma was examined in vivo. PBMC IL-4 secretion correlated significantly (P < 0.0001) with oestrogen levels. IFN-gamma varied as a function of serum DHEA-S in women and men [280] .
The effect of progesterone on apoptosis and oxidative burst activity of polymorphonuclear leukocytes (PMNs) challenged by Neisseria gonorrhoeae in vitro was investigated. P4 delayed the onset of apoptosis in N. gonorrhoeae. Staurosporine enhanced the production of superoxide anion of human PMNs stimulated by N. gonorrhoeae [281] . The progesterone metabolite allopregnanolone (AP) inhibits HPA response to IL-1beta in pregnancy. In late pregnancy, inhibition of 5alpha-reductase (an AP-synthesizing enzyme)
with finasteride restored HPA axis responses. AP reduced HPA responses in virgin rats. Naloxone restores HPA axis responses to IL-1beta in pregnancy [282] .
Hormonal contraceptives induce hyperplasia of the vaginal epithelium. The significant changes in the intraepithelial leukocyte population in depot-medroxyprogesterone acetate and levonorgestrel implant users most probably reflect altered local immune capacity [283] . During the luteal phase of the ovarian cycle, the immune response is shifted toward a Th2-type response, as reflected by increased IL-4 production. Increases of P4 and E2 in the luteal phase of the ovarian cycle play a role in the deviation of the toward a type-2 immune response [284] .
New Zealand White rabbits were studied for the effects of E2, and MPA, on infarct size. Infarct size was significantly reduced by E2. However, E2 + MPA did not reduce in infarct size. E2 also reduced serum levels of cardiac troponin I, immune complex in myocardial tissue, activation of the complement, and lipid peroxidation. MPA reversed these effects [285] .
Progetsrone Analogs, Agonists, Antagonists
The progesterone derivative dydrogesterone induced a decrease in the percentage of NK-1R+ lymphocytes. Th2-type cytokines were icreased and Th1-type decreased by dydrogesterone. An increased tail flick latency following dydrogesterone injection indicates that pain threshold was increased [286] . , and the corresponding sulfoxides and sulfones were synthesized and tested as blockers of dexamethasone (DEX) in rat thymocytes. DEX-mediated apoptosis and inhibition of the NFkappa-B transcription were tested. EP improved both parameters, while HEP improved only in blocking programmed cell death [287] . A new procedure is described for the preparation of 6,19-epithioprogesterone and related compounds. Antiimmunosuppresive activity was evaluated. Progesterone regulates secretory leukocyte protease inhibitor (SLPI) and elafin in the female reproductive tract even in the presence of inflammatory agents [288] . Collectively, our studies identified Irg1 as a novel target of PR in the pregnant uterus and that it is a critical regulator of the early events leading to implantation [289] .
Sulfur-bridged pregnanes 6,19-epithioprogesterone (EP),
In experimental animals, the importance of 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD) has been reported to be involved in the protection of immune cells from the toxic effects of progesterone [290] .
Progesterone and the synthetic progestogen, norethisterone (NT), have different effects on substance P (SP), neurokinin A (NKA) -like immunoreactivity in rat cortex and striatum. The effects of NT on SP-and NKA-like immunoreactivity in frontal cortex may contribute to the mood effects ascribed to this progestogen in clinical usage [291] .
We employed RU 486, a well-characterized PR antagonist that binds to the receptor and blocks its gene regulatory function. We performed mRNA profiling in the periimplantation uterus using oligonucleotide microarrays to analyze changes in mRNA levels in response to RU 486. Our study identified a variety of novel PR-regulated molecules, such as growth factors, protease inhibitors, metabolic enzymes, peptide hormones, transcription factors, immune response molecules, cytoskeletal proteins, and cell adhesion molecules, that are potential mediators of P action in the peri-implantation mouse uterus [292] .
II. SEX HORMONES AND DISEASE
1. GONADOTROPINS
Chorionic Gonadotropin
A single treatment with an oligopeptide from the betachain of hCG (NMPF) after high dose LPS inhibited septic shock in mice. This paralleled the downregulation of LPS effects on production of MIF by spleen cells, on the plasma level of liver aminotransferase, and on splenic lymphocyte and macrophage surface markers [293] .
hCG prevented development of diabetes in NOD mice. hCG decreased CD4(+) and CD8(+) T cells and inhibited T cell proliferation against beta cell antigens. hCG treatment suppressed IFN-gamma production, but increased IL-10 and TGF-beta production in splenocytes stimulated with anti-CD3 antibody [294] . The administration of hCG to NOD mice inhibits both the activation of diabetogenic CD4(+) and CD8(+) T-cells, in vitro and in vivo, and the progression of type 1 diabetes by upregulating the expression of IDO in DCs. IDO upregulation is transient and declined shortly after hCG withdrawal [295] . In NOD mice, HCG acts as an immune modulator and prevents the development of salivary gland exocrinopathy [296] .
PROLACTIN AND DISEASE
Prloactin and Stress
In patients undergoing chronic hemodialysis, PRL correlated directly with IFN-gamma and correlated inversely with IL-10; IFN-gamma correlated inversely with IL-4; and GH also correlated inversely with IGF-I and IL-4. However, IGF-I correlated directly with IL-2 and IL-10 [297] .
PRL-normal and PRL-deficient mice show differences in the myeloid cells if stressed. Corticosterone was higher in PRL-deficient mice. Pituitary graft lowered corticosterone levels. Immature neutrophils, granulocyte macrophages, monocyte/macrophages and granulocytes were higher in the stressed PRL-deficient mice [298] . PRL stimulates immunomodulating cytokines and lymphocyte-activating factors (e.g., IL-1) by peritoneal macrophages. PRL abolished the stress-induced inhibition of lymphocytes proliferation and increased cell sensitivity to IL-1 [299] .
Prolactin and Autoimmune Disease [300-305]
Polymorphisms of the human PRL gene have implications for production of lymphocyte PRL in SLE. Mild and moderate hyperprolactinemia (HPRL) has been demonstrated in 20-30% of SLE patients and is associated with active disease. HPRL stimulated the production of autoantibodies [306] .
Serum from SLE patients induces normal monocytes to differentiate into DC in correlation with disease activity depending on the actions of IFN-alpha, immune complexes, PRL, etc. High serum PRL levels have been found in a subset of SLE patients associated with active disease and organ involvement [307] . Two women with myasthenia gravis (MG) and thymic hyperplasia accompanied by prolactinomas are described. The levels of plasma PRL were raised in 101 women with MG, but not in 91 men. There was an association between high PRL levels and high levels of autoantibodies against the acetylcholine receptor [308] . Nine patients with relapsing-remitting MS (RR-MS) underwent cranial Gd-MRI once monthly for twelve months. From month six on, they received a single i.v.-infusion of 500 mg methylprednisolone (and oral tapering for three days) after the MRI. Monthly plasma prolactin showed a parallel decline (p = 0.027), with significant cross-correlation with the number of Gd+ lesions. Other hormones and immune system were unchanged [309] .
52 patients with diffuse syestemic sclerozis (SSc) were studied, (44 women and eight men) and 52 age and sex matched healthy controls. Significantly elevated prolactin was found in male and female patients and increased prolactin production by SSc lymphocytes [310] .
Mild to moderate hyperprolactinemia, similar to that present in SLE, induces a lupus-like illness in nonspontaneously autoimmune mice. Follicular B cells are T cell dependent, CD4+ T cells are necessary for the prolactinmediated break down of B cell tolerance. The effects of prolactin on the immune system are genetically determined [311] . In a cohort of SLE patients an increased frequency of the prolactin -1149 G allele was found compared with control subjects. Altered local prolactin production by immune cells may contribute to disease progression by affecting T cell function [312] . Prolactin increased significantly, while DHEAS showed a significant decrease in SLE patients compared with the controls (p<0.05), however the level of estrogen did not have any significant difference in SLE patients in comparison to controls [313] .
ACTH, PRL, cortisol, IL-1 beta and TNF-alpha circadian rhythms have been studied in active RA. RA patients had lower ACTH and cortisol levels and higher PRL and PRL/cortisol ratio when compared to controls. IL-1 beta and TNF-alpha reached their highest serum levels in RA patients at 2.00 and 6.00 h [314] .
The difference in EAE susceptibility in females is strongly influenced by gender-specific proinflammatory effects of IL-13, mediated in part through up-regulation of Th1-inducing cytokines and MHC II on CD11b(+) macrophages [315] .
Anti-prolactin auto-antibodies causing high prolactin values in some immunoassays can cause hyperprolactinaemia in adolescents without other signs of hormonal disturbances or auto-immune disease [316] .
Samples obtained from multiple myeloma patients (13 cases) not receiving chemotherapy for 6 months showed a positive reaction for PRL. The PRL-immunopositive bone marrow cells had disappeared after chemotherapy. PRLimmunopositive cells in the bone marrow were mainly, but not exclusively, plasma cells [317] .
The dopamine agonist bromocriptine, which inhibits pituitary secretion of prolactin, has been shown in a variety of small animal and human trials to reduce disease activity in SLE. Continued research may show that it can be an attractive alternative or adjacent therapy in cases where hydroxychloroquine is contraindicated [318] .
The molecular heterogeneity of prolactin was studied in the plasma of patients with active and inactive SLE and in healthy volunteers. Serum samples of SLE patients contained 130 kd and 23 kd prolactin. The 130-kd prolactin-like species was 10-fold higher in inactive SLE versus active SLE patients [319] .
Prolactin and Cancer
Three patients with SLE and prolactinomas are described. There was no consistency in the presence of findings related to prolactin excess or in the coincidence of hyperprolactinemia with flares of SLE disease activity [320] . PRL elevation in patients with prolactin-secreting pituitary tumors has been linked to increased prevalence of thyroid autoantibodies. Through the associated PRL, long-term antipsychotic treatment can induce thyroid autoimmunity [321] .
PRL protected the normal CD4+ CD8+ cortical thymocytes from DEX-induced apoptosis but failed to alter the effect of DEX in tumor-bearing mice (Elrich's ascitic carcinoma). The induction of tumor may alter the PRL-R that causes the failure of PRL in rescuing CD4+ CD8+ immature cortical thymocytes from GC induced death [322, 323] . Recombinant human prolactin administration to human colon adenocarcinoma HT-29-bearing SCID mice promoted the antitumor effects of adoptively transferred human NK cells [324] .
Prolactin and Infectious Disease
Twofold, threefold, fourfold and fivefold increase of PRL concentration above the normal was correlated to the decrease of the T. gondii seroprevalence, but only in the group of women with a very high PRL level (>86 ng/ml) seroprevalence (12.50%) was significantly lower (p = 0.0004) than in the control subjects [325] .
Cecal ligation and puncture in male mice led to mortality of 47% and decreased splenocyte proliferation and apoptosis. Administration of PRL (4 mg/kg s.c.) significantly increased the mortality of septic mice (81%). PRL augmented the inhibition of IL-2 and attenuated inhibition of IFN-gamma release in sepsis [326] .
Prolactin and Injury
Both PRL and phosphorylated PRL (S179D PRL) reduced the number of gammadeltaT cells. S179D PRL, but not unmodified PRL, maintained a normal LC:gammadelta T cell ratio and sustained the dendritic morphology of LC after UV exposure [327] . Mice were PRL normal, PRL deficient, or hyperprolactinemic and received a 15% total body surface area burn, sham treatment, or no treatment. Hyperprolacti-nemia attenuated the sham-induced decrease in monocyte/macrophage (M) colony formation. GM colony formation was not influnced by PRL status. Hypo or hyperprolactinemic animals responded to stress most frequently [328] . Under conditions of a controlled stress in mice (thermal injury) [a] the increase in the GM-CFU is exaggerated in the absence of PRL, and [b] the enhancement of PHA-induced proliferation of splenic lymphocytes required PRL [329] .
ESTROGENS AND DISEASE [330-347]
Female DBA/1 mice underwent ovariectomy or sham operation, and type II collagen-induced arthritis was induced ERalpha, but not ERbeta or GPR-30 signaling, ameliorated the disease and the associated development of osteoporosis [348] .
ERalpha-deficient (ERalpha(-/-)) and normal mice were injected monthly with E-2 starting at 8 weeks. In normal mice, E-2 treatment induced a lupus phenotype. Only minimal changes were observed in ERalpha(-/-) mice after E-2 treatment [349] .
EAE was examined in T-cell-deficient, severe combined immunodeficient mice or in immunocompetent mice with encephalitogenic T cells from wild-type estrogen receptoralpha (Esr1)+/+ or Esr1 knockout (Esr1-/-) donors and compared the protective E2 responses. The results showed that E2-responsive, Esr1+/+ disease-inducing encephalitogenic T cells were neither necessary nor sufficient for E2-mediated protection from EAE. Instead, the therapeutic response was mediated through direct effects on nonlymphocytic, E2-responsive cells and down-regulation of the inflammatory response in the central nervous system [350] . The beneficial effect of E2 on EAE does not involve ERalpha signaling in blood-derived inflammatory cells. It is clear that ERalpha expressed in other tissues, such as CNS-resident microglia or endothelial cells, mediates this effect [351] . By 1 year of age, mice lacking ERalpha (ERalpha(-/-)) but not those lacking ERbeta (ERbeta(-/-)) exhibit immune complex-type glomerulonephritis. No gender difference occurred. In female ERalpha(-/-) mice IgG3 was elevated. Other features were (i) spontaneous formation of germinal centers in the spleen wihout antigenic challenge and (ii) infiltration of plasma cells in the kidney and plasmacytosis in the spleen [352] .
ERalpha knockout mice revealed that both the estrogeninduced disease protection and the estrogen-induced reduction in proinflammatory cytokines were dependent upon ERalpha in the Th1-mediated autoimmune disease EAE [353] .
In mice ER alpha was expressed in all lymphocyte subsets examined. ER beta was expressed at low levels in thymic CD4/CD8-T cells in wild-type mice and at high levels in the peripheral CD4-/CD8-T cells in lpr mice. Both spontaneous and induced autoantibody production was higher in female lpr mice than in male lpr mice [354] .
An analysis of cytokine/chemokine secretion by MBP(Ac1-11)-specific T cells revealed unique ER1 and ER2 genotype-dependent regulation. Interferon-gamma was negatively regulated by ER1 whereas interleukin-6 and tumor necrosis factor-alpha were ER2 responsive. MCP-1 was regulation by ER1 and ER2. Experiments with reciprocal hematopoietic radiation bone marrow chimeras indicated that ER2 acted trough the nonhematopoietic compartment [355] .
Sex hormone-binding globulin (SHBG) regulates the bioavailability of sex hormones to target tissues. The SHBG327Asn variant contributes to the development of SLE. The SHBG327Asn variant displays a reduction of estradiol clearance [356] .
In female mice protected from EAE estrogen significantly affected the transcription of 315 genes, 302 of which were down-regulated and 13 up-regulated by > or = 2.4 fold. Genes encoding the MHC complex, cytokines/receptors, chemokines, adhesion molecules, and signal transduction proteins were strongly down-regulated (> 20 fold) [357] .
Oral tolerance induction in mice suppressed the occurrence of arthritis, the proliferative response of splenocytes to type II collagen (CII) and the specific DTH response. However, E2 treatment abrogated the suppression, which might be due to a change in function of Peyer's patch lymphocytes [358] .
Endothelial cells of newborns to SLE+ mothers are in a proinflammatory condition, which can be upregulated by estrogens [359] .
Whereas all intact, female mice injected with 20 microg estrogen at 5-7 days of age had ovaries with follicular cysts, no cysts were observed in animals in which thymectomy at 3 days of age preceded estrogen injection. In fact, after restoring immune function by thymocyte replacement, the majority of thymectomized, estrogen-injected mice had ovaries with corpora lutea. Thus, when estrogen is unable to act on the thymus, ovulation occurs and follicular cysts do not develop. The disease is transferable by lymphocyte infusion. Transfer took place between 100-day-old estrogen-injected and 15-day-old naïve mice only when recipients were thymectomized at 3 days of age [360] .
It is well established in MS that the frequency of relapses decreases in late pregnancy, but increases in the post-partum period. This protective effect is probably due to hormonal and immune response changes induced by pregnancy. Oestrogens may be responsible, at least in part, for this protective effect [361] . The treatment of experimental autoimmune myasthenia gravis (EAMG) with E2 before antigen priming was necessary and sufficient to promote AChR-specific Th1 cell expansion in vivo. This enhances the production of antiAChR IgG2a(b) and IgG2b, but not IgG1, and increases the severity of EAMG in mice [362] .
Arthritis induction to castrated and ovariectomized rats resulted in enhanced inflammation. Treatment with physiological doses of dihydrotestosterone and estrogen attenuated the inflammation, with estrogen exhibiting higher potency. Progesterone did not modify the disease alone and when administered with estrogen, the protective effects of estrogen were decreased [363] . Estrogen and relaxin (RLX) was more effective than either hormone alone in blocking secondary paw inflammation adjuvant-induced arthritis (AIA) in ovx Lewis rats; reduced changes to spleen and thymus weight, decreased circulating TNF alpha and increased IL 10 [364] . Severe autoimmune arthritis developed in younger ovx-MRL/lpr mice, which healed after estrogen administration.
Elevation in serum rheumatoid factor, anti-double-stranded DNA, and anti-type II collagen was found and recovered after estrogen administration. CD4(+) T cells bearing nuclear factor-kappaB ligand (RANKL), enhanced expression of RANKL mRNA , impaired osteoprotegerin mRNA was detected in the synovium. Osteoclast increased and bone resorption pits were found [365] .
The loss of endogenous estrogen and inflammation contribute additively and equally to osteoporosis in experimental postmenopausal polyarthritis. Markers of bone remodeling and bone marrow lymphocyte phenotypes indicate different mechanisms for the development of osteoporosis caused by ovariectomy and arthritis in this model [366] . The prevalence of pro-inflammatory hormones in synovial fluid of RA patients show the possible role of these steroid hormones in inflammatory processes [367] . Twelve patients with RA and 8 subjects with traumatic knee injury (noninflammatory controls) were studied. Synovial fluid (SF) contained significantly elevated levels of estrogens relative to androgens, while androgens were markedly reduced, in patients with RA compared to controls [368] .
The increased susceptibility of female NOD mice to the development of autoimmune diabetes could be due to the enhancement of the Th1 immune response through the increase of IL-12-induced STAT4 activation by estrogen [369] .
Seventeen consecutive pregnant SLE patients and 8 matched healthy pregnant controls were studied. In SLE patients, estradiol, progesterone, and DHEAS concentrations were found to be significantly reduced compared with controls. No differences in the steroid levels were observed between patients taking prednisone [370] .
EAE disease severity in both female and male mice was decreased with estriol treatment. Proinflammatory cytokine production during autoantigen-specific immune responses was decreased with estriol treatment in both females and males [371] .
Estrogen Analogus, Agonists, Antagonists
Treatment with an ERalpha ligand, PPT, is highly selective in vivo, mediating both anti-inflammatory and neuroprotective effects in EAE [372] . Ovariectomized NZB/NZW F1 mice treated with PPT aggravated the development of murine SLE. In contrast, DPN (ERbeta-selective agonist) administration reversed the symptoms of the disease [373] .
The ER antagonist ICI 182 780 reversed the suppressive effects of E2 on murine lupus. Treatment of SJL mice with the ERalpha-selective agonist PPT prior to the induction suppressed the disease, but ERbeta-selective agonist (WAY-202041) had no effect. Treatment of mice with PLP peptide 139-151 (PPT) was also associated with decreased immune responses in disease. Raloxifene and WAY-138923 also suppressed the disease [374] . Tamoxifen treatment significantly reduced autoantibody production directed against either nuclear extract or DNA of the IgG3 isotype. Tamoxifen had a therapeutic effect on SLE in (NZBxNZW)F1 mice [375] . E2 given i.p. reduced contact hypersensitivity (CHS) in UVB-irradiated mice, and tamoxifen or antiestradiol antibody significantly promoted the UVB-effects. E2 decreased the serum IL-10 and tamoxifen or antiestradiol antibody increased the serum IL-10 [376].
Estrogen and Trauma
DHEA stimulates proinflammatory cytokine release from human PBMCs following major abdominal surgery. The estrogen receptor appears to be involved in mediating the immunomodulatory effect of DHEA. Thus, DHEA might be a useful adjunct for preventing immunosuppression in surgical patients [377] .
Aromatase and 17beta-hydroxysteroid dehydrogenases increase E2 synthesis and low conversion into estrone in T lymphocytes of proestrus but not of ovx mice. E2 stimulates T lymphocytes to release IL-2 and IL-6 via ER-beta. E2 maintains T lymphocytes of proestrus females after traumahemorrhage (TH) [378] . The inhibitory effect of estradiol on Kupffer cell function is mediated via downregulation of TLR4-dependent p38 MAPK and NF-kappaB signaling following trauma-hemorrhage, which prevents the systemic release of cytokines [379] . The inhibition of 5alpha-reductase leads to the conversion of testosterone to 17beta-estradiol, which has a normalizing effect on the posttraumatic immune response [380] . Sex steroids not only modulate the immune/cardiovascular responses but also influence various metabolic processes following trauma. Thus, alteration or modulation of the prevailing hormone milieu at the time of injury appears to be a novel therapeutic adjunct for improving outcome after injury [381] . Both ER-alpha and ER-beta receptors appear to play a significant role in mediating the immunoprotective effects of E2 in different tissue compartments following trauma-hemorrhage [382] . After traumatic injury DTH response was suppressed >75% in the in aged female mice. E2 given before injury led to recovery to 40 % suppression. IL-6 was increased fourfold in burn-injured, aged mice. E2 treatment lowered this by nearly 50%. E2 improved survival from 42% to 70% in aged, burninjured mice [383] . Castrated mice were hormonally treated and then subjected to soft-tissue trauma (i.e. midline laporatomy), hemorrhagic shock and 24 h later cecal ligation and puncture was done. 5alpha-Dihydrotestosterone-treated mice showed a depressed pro-inflammatory cytokine production splenic macrophages and PBMC. E2 was able to prevent immune dysfunction after TH and subsequent sepsis, which was limited to splenic macrophages [384] .
Aged male and female CBA/J mice (18-19 months) were subjected to hemorrhage (35 +/-5 mmHg for 90 min) or sham operation. Early recombinant murine (rm) IL-10 treatment restored immune function in aged females, but not in males [385] .
The complete deficiency in aromatase in mice correlated with a decrease in the production of the inflammatory cytokine IL-6 and partial restoration of the DTH response after severe burn. However, a deficiency of aromatase did not affect TNF alpha production after injury [386] .
Estrogens and Infection
Pregnant hamsters infected with Leishmania (Viannia) panamensis, at 7 days post-infection showed a lower parasite burden compared with nonpregnant controls at the cutaneous infection site (P=0.0098) and draining lymph node (P=0.02). This resistance was mediated by macropages via NO production, which was also produced by neutrophils [387] .
In mice, the incidence of cerebral malaria was 50%, and plasma TNF-alpha increased and brain NOS activity decreased compared to non-infected controls. Castration had no major effect. Estradiol replacement decreased parasitemia but resulted in higher malaria incidence and faster mortality, with an increase in NOS activity [388] .
The effect of E2 on the maturational response triggered by Newcastle disease virus was examined in human DCs and its influence on their ability to activate naive T cells. E2 pretreatment down-regulated the antiviral response to RNA viruses in DCs by suppressing type I IFN synthesis. DCs capacity to stimulate naive CD4 T cells was reduced [389] . Estrogen impairs the defense mechanisms of the genital tract of non-castrated female rats, enhancing bacterial growth in the vagina and ascending infection to the uterus, tubes and ovaries [390] .
Estrogen and inflammation
Pelvic inflammation is triggered primarily by LPS and is mediated by toll-like receptor 4 and is involved in the development of pelvic endometriosis. Peritoneal macrophages, estrogen and progesterone and hepatocyte growth factor (HGF) play a role. HGF is a pleiotropic growth factor, retains multifunctional role endometriosis [391] .
Estrogens and Gestational Pathophysiology
During the third trimester of pregnancy, ex vivo monocytic IL-12 production was about 3-fold and TNF-alpha production was approximately 40% lower than postpartum values. At the same time, urinary cortisol and norepinephrine excretion and serum levels of 1,25-dihydroxyvitamin were 2-to 3-fold higher than postpartum values. These hormones can directly suppress IL-12 and TNF-alpha production by monocytes/macrophages in vitro [392] .
The weal and flare reaction after intradermal injection of estradiol and progesterone was compared in 29 women with recurrent miscarriage to the response in 10 healthy women. Estrogen hypersensitivity was found in 23 patients, and progesterone hypersensitivity in 20 patients. No patient in the control group demonstrated sex hormone hypersensitivity [393] .
Estrogens and Cytotoxicity
Three lines of stably transfected HeLa cells expressing wild-type proteinase inhibitor 9 (PI-9, SerpinB9) and one line expressing an inactive mutant PI-9 were isolated and tested. Expressions of wild-type PI-9, but not the inactive mutant PI-9, inhibited cytolysis induced by human NK92 and NKL natural killer cells. Estrogens exert a strong stimulus for PI-9 production and so does tamoxifen [394] .
Estrogens and Stress
The levels of plasma corticosterone and catecholamines were significantly higher during stress exposure in FIS as compared to LEW rats. Greater decrease of testosterone levels and higher levels of estradiol were noted after exposure to stress in LEW rats. Higher values of progesterone plasma levels were present in FIS rats after stress [395] .
Injury and ethanol exposure independently affect cellular immune responses, delayed-type hypersensitivity and splenocyte proliferative responses, and combined insult acts in conjunction to increase further immunosuppression. These immune responses are restored in male, but not in female, mice by administration of low, proestrous levels of estrogen [396] .
Estrogens and Cancer
Estrogens strongly induce the human granzyme B inhibitor, PI-9. Estrogen induction of PI-9 protected the liver cells against CTL and NK cell-mediated, granzyme-dependent, apoptosis. Knockdown of PI-9 by RNA interference blocked the protective effect of estrogen [397] .
PROGESTOIDS AND DISEASE [398-401]
Increased serum progesterone levels exacerbate the allergic asthmatic phenotype in a mouse model. These effects are further exacerbated by the addition of environmental tobacco smoke. Progesterone provides a major contribution to the gender differences seen in the development and elicitation of the asthmatic response [402] .
One hour after bilateral injury to the medial frontal cortex, adult male rats were given injections of progesterone (16 mg/kg) for 2 days. Complement C3, glial fibrillary acidic protein and NFkappaB p65 were increased in all injured animals. In animals given progesterone post-injury, NFkappaB p65 and the inflammatory metabolites of C3 (9 kDa and 75 kDa) were decreased in comparison to vehicle-treated animals [403] . A potential and novel function of progesterone that it increases the vulnerability of neurons to apoptotic injury in EAE and may have pathophysiologic implications in the progression of disability in women with MS [404] .
In the setting of inflammation-induced preterm birth, the host immune response is activated and not limited to a traditional TH1 bias. The ability of medroxyprogesterone acetate to modulate the immune response may be a critical mechanism by which progestins prevent preterm birth [405] . Stress induced abortions in mice and humans occur putatively via increased levels of abortogenic Th1 cytokines and a decrease of progesterone. Adequate levels of progesterone induces the release of PIBF which is highly pregnancy-protective by induction of a Th2 biased immune activity. The progesterone derivative dydrogesterone abrogates stress-triggered abortion by inducing a Th2 biased local immune response [406] . Progesterone substitution in mice abrogated the abortogenic effects of stress exposure by decreasing the frequency of abortogenic cytokines. This pathway was exceedingly CD8cell dependent, because depletion of CD8cells led to a termination of the pregnancy protective effect of progesterone substitution [407] . Following recognition of fetally derived antigens gamma/delta TCR+ cells develop progesterone receptors. Progesterone binding results in the synthesis of PIBF. PIBF induces a Th2 biased immune response, and controls NK activity, which has an anti-abortive effect [408] .
Progesterone is indispensable for creating a suitable endometrial environment for implantation. Repeated miscarriage may be due to subnormal progesterone secretion and retarded endometrial development in the peri-implantation period. Progesterone also acts on the immune system, mainly by affecting cytokine synthesis and the function of NK cells [409] . Polycystic ovary splenocytes might exert a protective action against the disease effects through their secretions by inducing a low androstenedione response from the ovary [410] .
Progesterone and Infections
The anti-estrogen tamoxifen, reduced parasite loads 100% in infected mice of both sexes treated with progesterone. These results suggest that progesterone, possibly through its metabolism to estradiol, affects establishment, growth and reproduction of the helminth parasite T. crassiceps [411] .
Following Depo-provera-treatment, mice had prolonged diestrus that lasted more than 4 weeks. This coincided with a 100-fold increase in susceptibility to genital HSV-2. Normal, untreated mice in estrus were not susceptible to HSV-2. Depo-provera treatment had inhibitory effects on immune responses to HSV-2 [412] . The immunosuppressive effect of Depo-Provera on mounting an antiviral cellular immune response may account for the increased viral burden and diversity, and the predominance of X4 virus replication in SHIV infected macaques that were administered the progestin-based contraceptive [413] . Progesterone increases and estradiol decreases susceptibility to intrauterine chlamydial infection in rats [414] .
HORMONAL THERAPY
Hormone Replacement Therapy (HRT) [415, 416]
Oral hormonal replacement therapy may be involved in the development of cardiovascular disease through inflammatory mechanisms, as suggested by increased serum levels of the complemnt components C3 and C4 [417] . In a controlled study, the main in vivo effect of estrogens was a decrease in IL-6 production, indicating a possible beneficial effect of estrogen therapy [418] . Decrease of IL-6 in parallel with no effect on some indices of immune activity suggests a beneficial action of transdermal HRT [419] . In women taking intranasal or transdermal E2, C reactive protein (CRP) did not change. In women taking oral E2, serum median CRP levels were significantly higher. Serum IL-6 was lower in women taking E2 intranasally, orally or transdermally (P < 0.05) [420] .
Healthy young and old ovariectomized rhesus macaques were given transdermally estrogen and progesterone. This treatment decreased lymphocyte numbers and downmodulated activation markers. PBMC decreased as did IFNgamma production, but not Ig production. Young animals were most susceptible to hormone treatment [421] .
PHA-stimulated PBMC from 15 healthy postmenopausal women given estrogen/medroxyprogesterone HRT showed decreased NK cell cytotoxicity, IL-2 and IFN-gamma, and IL -4 was unchanged. E2 was increased, Kupperman index and FSH were decreased [422] .
In postmenopausal hemodialysis patients, hormone HRT significantly increased CD4+ numbers and CD4+ / CD8+ ratio, but no effect was observed in IgM, IgG, and IgA levels. Dialysis patients need furter investigations for the longterm clinical effects of HRT on the immune system [423] .
Long-term HRT in RA does not influence Ig or autoantibody in serum and has no significant impact on humoral and cell-mediated immune responses to recall antigens. High disease activity was associated with increased humoral but decreased cell-mediated immune responses irrespectively of hormone treatment [424] . Progesterone withdrawal results in a local increase of inflammatory mediators and the enzymes responsible for tissue breakdown. The total complex of local factors implicated in normal menstrual and aberrant menstrual bleeding are yet to be fully defined [425] .
Thirteen women exposed to DES in utero were compared with 13 age-and menstrual cycle phase-matched control subjects. H3-thymidine incorporation by T cells from DESexposed women was increased 3-fold, the PHA response was increased by 50% and the response to endogenus IL-2 increased 2-fold [426] .
Hormone Therapy [427]
Multiple Sclerosis (MS) and EAE
Supernatants from PBMCs of estriol treated female MS patients decreased MMP-9, which coincided with decrease in enhancing lesion volume. Estriol treatment of mice with EAE reduced MMP-9 in supernatants from autoantigenstimulated splenocytes, coinciding with decreased CNS infiltration by T cells and monocytes. This effect was mediated through ERalpha [428] . Significantly increased levels of IL-5 and IL-10 and decreased TNF-alpha were observed in stimulated PBMC isolated from estriol treated patients with relapsing remitting MS. These changes in cytokines correlated with reductions of enhancing lesions of MS. IL-5 and IL10 were increased, and TNF alpha decreased [429] .
Young C57BL/6 male mice developed an acute EAE and a partial remission, and middle-aged males had severe chronic and unremitting EAE. CD4+CD25+ regulatory T activity and splenic CD4+ T cells were reduced; MHC class II-expressing cells, and IFN-gamma and MCP-1 were enhanced. Middle-age males had transient benefit from E2 treatment; young males were protected by hormone treatments. T4 treatment of young males inhibited proliferation of myelin antigen specific T cells and secretion of TNFalpha and IFN-gamma. The androgen receptor antagonist, flutamide, reversed these effects of T4 cells [430] .
E2 and Estriol inhibited active EAE in mice. Inflammatory foci were reduced in the CNS of E2 or estriol-treated mice. T cells from low-dose estrogen-treated mice suppressed EAE upon transfer. A modest shift in Th1/Th2 balance occurred. Estrogen treatment at the onset of active EAE failed to reduce disease severity [431] .
Systemic Lupus Erythematosus (SLE)
Gene expression profiles of blood from SLE patients and from healthy women were analyzed by DNA microarray analysis. Thirty-eight downregulated genes and 68 upregulated genes were found. Interferon-inducible genes were overexpressed. TNF-regulated genes were dominant and had repressive effect. IFNgamma essentially has synergistic effects on interferon-inducible gene expressions. E2 showed variable effects [432] .
Arthritis
Eight of eleven samples of RA synovial fluid were found to inhibit spontaneous and immune complex-stimulated neutrophil apoptosis. No relationships were found between GM-CSF and TNF-alpha or estradiol concentrations. The antiapoptotic activity correlated with the adenosine concentrations in each sample [433] .
Bone
Mice were ovx, and were administered E2, raloxifene or genistein. Ovx induced uterine atrophy and thymic hypertrophy. Raloxifene corrected thymic hypertrophy, and E2 corrected both. Ovx mice had increased serum calcium and cathepsin K and decreased serum alkaline phosphatase. Ovx increased B-cells and CD25+ cells, and decreased T-cells and Cbfa1 gene expression in bone marrow. All ER agonists corrected [434] .
Infection
Ovariectomized mice were administered either saline (control), E2, P4, or a combination of both (E+P) and infected intravaginally with herpes simplex virus type 2 (HSV-2). P4-treated mice were highly susceptible to genital HSV-2 infection. 100% of mice succumbed by day 4 postinfection. E2-treated mice were protected from HSV-2 infection. In the combination hormone-treated group 80% of animals succumbed by day 13 [435] .
Infectious Disease
Methamphetamine and cocaine cause synergistic neurotoxic effect during the course of HIV dementia, and estrogens prevented these synergistic neurotoxicities during HIVdrug interactions [436] .
Peripheral blood mononuclear cells were collected from beagle bitches during different stages of the estrous cycle. The proliferative response of PBMNCs to PYO-252, a clone of E coli significantly decreased in the first half (day 10) of diestrus, but increased in proestrus/estrus and it was enhanced by E2 and suppressed by P4. E2 also enhanced IFN gamma, which was suppressed by P4. PBMNCs did not respond to LPS derived from E. coli [437] .
Diarrhea
HLA-B27 transgenic rats with chronic diarrhea were treated with 17alpha-ethynyl-17beta-estradiol (EE) for 5 days. EE treatment dramatically improved stool scores after only 3 days. Histological scores also improved. Neutrophil myeloperoxidase (MPO) activity levels were reduced by 80%. The pure ER antagonist, ICI-182780, blocked the effects of EE on stool character, MPO activity, and histology scores [438] .
Trauma-Hemorrhage
Male rats underwent trauma-hemorrhage and fluid resuscitation. The ER-alpha agonist PPT, the ER-beta agonist DPN, E2, or vehicle (10% DMSO) was injected s.c. during resuscitation.. Kupffer cells increased IL-6 and TNF-alpha production; and splenic macrophages, alveolar macrophages, PBMC had decreased release of these cytokines. IL-10 production increased in all macrophage populations. E2 and DPN prevented all of these alterations [439] .
Cancer
E2 treatment inhibited the growth of all four androgenindependent prostate cancer (CaP) xenografts studied (LuCaP 35V, LuCaP 23.1AI, LuCaP 49, and LuCaP 58) in castrated male mice. Multiple pathways are altered by E2 treatment. Proteins that mediate immune responses and regulate androgen receptor signaling have relevance [440] . In breast cancer cells, estrogen induce granzyme B PI-9 and block cell death induced by NK92 natural killer (NK) cells, but do not block killing by a second NK cell line, NKL cells. Tamoxifen but not raloxifene or ICI 182,780, blocks killing by both NK92 and NKL cells [441] .
Parasite Immunity
Taenia crassiceps cysticercosis results in feminization in male mice during chronic infection, characterized by increased serum E2 levels 100 times normal values, while those of testosterone and dihydrotestosterone are decreased by 85 and 95% respectively. FSH and IL-6 are increased 70 and 90 times. Immune depletion was done by total body irradiation and neonatal thymectomy. Such male mice did not feminize, and the levels of FSH and IL-6 were inhibited. In IL-6(-/-) knockout mice there is no feminization process, while restitution of the IL-6(-/-) knockout, irradiated, and thymectomized mice with murine recombinant IL-6 restored the feminization process. Expression of the IL-6 gene was found only in the testes and spleen of infected animals [442] .
Drug Action
E2 inhibits, and testosterone synergise with the antiproliferative/immune suppressive drug Leflunomide metabolite A77 1726 LEF-M activity [443] .
CONCLUSIONS: IMMUNOREGULATION BY SEX HORMONES
Neuroimmune Biology (NIB) has developed during the past 30 years into a reputable area of modern biological sciences. Already patients are beginning to benefit from the discoveries made in this field. Here some reflections are given on the reviewed material. This evidence is strong testimony for the existence and fundamental importance of the Neuroimmue Supersystem (NISS) [444] . There could be no denial of the coordinative regulatory role of NISS in higher organisms.
Many investigators view their problem as if it was a matter of the effect of one hormone, like estradiol on a variable of interest, such as cytokines, cells, tissues or organs etc. Very few investigators delt with the problems investigated as looking at one part of the entire organism, the body where there is an elaborate network of regulatory circuits which will sense and initiate reactions to every event while communicating with the Central Nervous System (CNS). No hormonal effect, no biological response, or pathological event can proceed independently. Neurons express innate immune receptors, so the CNS itself would recognize patho-genic insults and other conditions directly. Cytokines carry immune inflammatory signals directly to the brain and also via sensory nerves. Mediators like the complement components C3a and C5a, bradykinin, mast cell derived neuropeptides etc. all signal the brain about immune inflammatory processes [445] . In short no physiological or pathological process can proceed without the regulatory influence of NISS. Therefore, when performing in vivo experiments, one should always be aware that interaction is going on with the entire organism. Many papers miss this aspect of their work. The view cannot be taken that estrogens causing immune modulation on their own, or elicit disease, or protect, whatever the case may be. Yes steroid hormones are powerful, but not absolute regulators. They interact and are subjected to higher regulatory circuits within the organism. One always must be aware of the complexity of the system investigated.
The body is regulated by superimposed regulatory circuits. First is the circuit formed by the CNS and its nerves, the second is the pituitary gland with its feed forwards and feedback mechanisms, next is the circuits of the endocrine target organs, such as the thyroid, gonads, adrenals and somatic cells and tissues. Individual cells form the last circuit as they may be able to function on their own. A lymphocyte would respond to stimulation by innate antigens or cytokines on its own, for instance. In case of failure of a higher regulatory circuit (e.g. CNS) a lower regulatory circuit may be activated by innate immune (Toll-like) receptors and by cytokines, so that host defense and other functions could carry on. This organization ensures that the biological processes in the body are never without regulation [446] .
Immune Function
The traditional view is that immune system is autonomous and protects the host from infections and cancer. T and B-lymphocytes and other leukocytes were thought to participate in immunity, self-tolerance, and in immunological memory. It emerged slowly but by now conclusively that the immune system protects against cancer. Even when tumor specific antigens are not available, the immune system can develop autoimmune reactions against self-antigens and kill tumor cells by this response [447] . This implies that the immune system is capable of detecting quantitative changes, like the proliferation of tumor cells and develops protective autoimmune reactions against cancer cells. This phenomenon is likely dependent on the quantitative nature of suppression by regulatory cells that work by cell-to-cell contact. So the argument that autoimmune reactions are pathological seems to be an oversimplification. Autoimmune reactions are part of the normal immunological armamentarium.
In females during gestation the fetus must not be rejected, but rather nourished and protected. This is a job for the entire female organism. Adaptive immune function is tamed in the female reproductive tract by suppressor mechanisms, which are induced and maintained by neuroimmune regulatory mechanism; prolactin, estrogens, progesterone, glucocorticoids and vitamin D are the key regulatory hormones [392] . Cell mediated immunity is suppressed while antibody formation is maintained. During pregnancy lymphocytes and NK cells migrate into to pregnant uterus, apparently to perform benign, protective/trophic effect. The fetus relies on innate immunity for protection. The trophoblast was also proposed to exert a protective effect for the fetus [448, 449] . The profound hormone production by the placenta, which eventually over powers the mother's endocrine system is another mechanism for the protection of the fetus even against the mother's interest [450] . Much remains to be learnt about the neuroimmune biology of pregnancy.
Is it possible that the powerful immunoregulatory mechanisms that operate during pregnancy get loose and disorganize normal immune function? Immnoregulation by hormones are ultimately controlled by nuclei residing in the CNS. One key question is where the defect occurs when immune dysfunction arises. Common sense would indicate that the defect could be within the immune system, in the endocrine system or in the relevant centers in the CNS. One must keep in mind everything what is relevant. We also should remember that each system has a certain potential for autonomy.
The immune system does not only protect against infections and cancer, but rather has the capacity to protect against harmful noxious agents, which are sensed by innate immune receptors and innate immunity is activated by such agents. We might say that the immune system has the capacity to protect the host regardless of the cause of disease [445] .
The Brain as Immunoregulator
EAE was induced in T-cell-deficient, severe combined immunodeficient mice or in immunocompetent mice with encephalitogenic T cells from wild-type Esr1+/+ or Esr1 knockout (Esr1-/-) donors and compared the protective E2 responses. E2-responsive, Esr1+/+ disease-inducing encephalitogenic T cells were neither necessary nor sufficient for E2-mediated protection from EAE. Instead, the therapeutic response was mediated through direct effects on nonlymphocytic, E2-responsive cells and down-regulation of the inflammatory response in the central nervous system [350] . The beneficial effect of E2 on EAE does not involve ERalpha signaling in blood-derived inflammatory cells, but ERalpha expressed in other tissues, such as CNS-resident microglia or endothelial cells, mediate this effect [351] .
The above papers imply that estradiol mediated inhibition of EAE does not depend on lymphocytes but rather, the CNS is involved in protection. These findings identify the CNS for protection against autoimmune disease. We proposed earlier that allergy and asthma are not immunologically mediated diseases but rather, they are due to must cell hypersensitivity to various stimulants, which is controlled by the CNS [445] . The CNS is now an active participant in the innate immune system and it has commanding roles in the regulation of immune and inflammatory reactions. These recent data indicate that the ultimate regulatory power of immune/inflammatory reactions is the CNS.
Hormonal Regulatory Networks
Active steroids are synthesized locally in target tissues, either from circulating inactive precursors or de novo from cholesterol. Steroids are synthesized in the brain (neurosteroids) and steroids synthesized in the immune system (immu-nosteroids). Furthermore, recent evidence suggests that other components of the HPG axis (luteinizing hormones and gonadotropin-releasing hormone) and HPA axis (adrenocorticotropic hormone and corticotropin-releasing hormone) are expressed locally in target tissues, potentially providing a mechanism for local regulation of neurosteroid and immunosteroid synthesis. Individual tissues and organs may become capable of autonomously synthesizing and modulating local steroid signals, perhaps independently of the HPG and HPA axes [451] .
The effect of insulin, oxytocin, gonadotropin and epidermal growth factor on the production of ACTH, endorphin, triiodothyronine in immune cells was studied. All of the hormones studied influenced the hormone concentration of immune cells significantly. The effects showed the following order:oxytocin > gonadotropin > EGF > insulin. In the case of oxytocin, 8/12 of the hormone/cell group was affected, while treatment with insulin affected only 4/12. ACTH production was reduced everywhere except in the insulin-thymocyte setup. Endorphin and T3 production was always elevated. Cells of the monocyte-granulocyte group were more sensitive to hormonal regulation than peritoneal lymphocytes. The concept of a hormonal network within the immune system can be proposed [35] .
The above observations are in line with similar observation in the past that classical hormones are produced in multiple organs and tissues [452] . This sharing of mediators makes it possible to communicate, but also, may enable the organ, tissue to function autonomously with a full range of regulatory hormones being available locally.
Network Regulation
ERalpha activation plays the predominant and immunostimulatory role in estrogen-mediated modulation of lupus while ERbeta activation appears to have a slightly immunosuppressive effect on this disease. ERalpha activation coincidentally increased serum prolactin concentrations and may accelerate lupus disease activity through this mechanism as well [373] . In multiple studies, elevated serum prolactin concentrations (hyperprolactinemia) stimulated appearance or progression of murine lupus. Autoimmune disease acceleration by prolactin appears to be accentuated by estrogen stimulation of prolactin secretion and independent of immunosuppressive effects of androgens such as testosterone. Conversely, suppression of serum prolactin concentrations by bromocriptine inhibits development of murine SLE [313, 318] .
The neurimmune networks that are involved in systemic lupus erythematosus are the hypothalamic-pituitary-adrenal axis, cytokines within the central nervous system, and the sympathetic system. Hormones (estrogen, prolactin, gonadotropin-releasing hormone, and leptin) play an important role as immunomodulatory agents [346] .
Peripheral blood leukocytes of healthy male subjects were treated with sex hormones (for 24 h) with or without additional treatment with cortisol (for another 24 h). The effect on the secretion of TNF, IL-2, IL-4, IL-6, IL-10, and interferon-gamma (IFN-gamma) was examined. E2 stabilized or increased the immune stimuli-induced secretion of TNF, IL-2, IL-4, IL-6, IL-10, and IFNgamma in relation to testosterone. Testosterone, inhibited (IL-2, IL-4, IL-10) or tended to inhibit the stimulated secretion of these cytokines (TNF, IFNgamma). This effect of E2 was pronounced at a concentration of 10(-10) M (testosterone: 10(-7) M) in the presence of cortisol. E2 (10(-8) M, 10(-10) M) and testosterone (10(-7) M) did not change glucocorticoid receptor expression. The downstream estrogens 2OH-estradiol(one), 4OH-estradiol(one), and 16OH-estradiol(one) did not stimulate TNF secretion at 10(-10) M, but even inhibited its secretion at 10(-11) M. However, the combination of 16OH-estradiol(one) on one side and 2OH-estradiol(one) or 4OH-estradiol(one) on the other side markedly stimulated TNF secretion that was only observable in the presence of cortisol. At physiological concentrations, E2 and a combination of downstream estrogens stabilized or increased immune stimuli-induced TNF secretion. These effects are dependent on the presence of physiological concentrations of cortisol. This study underlines the proinflammatory role of E2, which is probably dependent on conversion to a proinflammatory cocktail of downstream estrogens and the presence of cortisol [112] .
Glucocorticoids, sex steroids, and dopaminergic drugs modulate macrophage FcgammaR expression. Estradiol increases macrophage FcgammaR expression. The effects commonly used estrogens was examined on the expression of macrophage FcgammaRs using a guinea pig experimental model. Six estrogens have been studied: ethynylestradiol (Et), mestranol (M), chlortianisene (Ct), promestriene, 17-epiestriol, and 17beta-estradiol. Estrogens enhance the clearance of IgG-sensitized erythrocytes by increasing splenicmacrophage FcgammaR expression. Et, M, and Ct were more effective than the other estrogens. Estrogens increase the cell surface expression of FcgammaR1 and -2 more than that of FcgammaR2 [177] .
Healing
The process of healing is also regulated by neuroimmune mechanisms. Vasopressin regulates immune function during healing [453] . In this review healing and disease prevention was observed in several situations: e.g. E2-reduced the clinical severity of EAE. ERalpha ligand treatment was antiinflammatory, ERbeta ligand treatment was not. ERbeta ligand reduced demyelination and prevented neuronal abnormalities in gray matter. ERalpha ligand abrogated the disease ERbeta ligand treatment promoted recovery [231] . EAE disease severity in both female and male mice was decreased with estriol treatment. Proinflammatory cytokine production during autoantigen-specific immune responses was decreased with estriol treatment in both females and males [264] .
Ovariectomized NZB/NZW F1 mice treated with propyl pyrazole triol (ER alpha-selective agonist) aggravated the development of murine SLE. In contrast, diarylpropionitrile (ERbeta-selective agonist) administration reversed the symptoms of the disease [373] . E2 and Estriol inhibited active EAE in mice. Inflammatory foci were reduced in the CNS of E2 or estriol-treated mice. T cells from low-dose estrogentreated mice suppressed EAE upon transfer. A modest shift in Th1/Th2 balance occurred. Estrogen treatment at the onset of active EAE failed to reduce disease severity [431] .
Ovariectomized mice were administered either saline (control), E2, P4, or a combination of both (E+P) and infected intravaginally with herpes simplex virus type 2 (HSV-2). P4-treated mice were highly susceptible to genital HSV-2 infection. 100% of mice succumbed by day 4 postinfection. E(2)-treated mice were protected from HSV-2 infection. In the combination hormone-treated group 80% of animals succumbed to infection by day 13 [435] .
The ability of two commercially available SERMs (tamoxifen and raloxifene) to regulate myelin specific immunity was investigated in experimental autoimmune encephalomyelitis (EAE) of mice. Both tamoxifen and raloxifene suppressed myelin antigen specific T-cell proliferation. However, tamoxifen was more effective in this regard. Tamoxifen treatment reduced the induction of major histocompatibility complex II by lipopolysaccharide stimulated dendritic cells and decreased their ability to activate myelin specific T-cells. At lower doses, tamoxifen was found to increase the levels of Th2 transcription factors and induce a Th2 bias in cultures of myelin-specific splenocytes. EAE symptoms and the degree of demyelination were less severe in mice treated with tamoxifen than in control mice [454] .
The anti-estrogen tamoxifen, reduced parasite loads 100% in infected mice of both sexes treated with progesterone. These results suggest that progesterone, possibly through its metabolism to estradiol, affects establishment, growth and reproduction of the helminth parasite T. crassiceps [440] .
The peptide hormone prolactin may be associated with SLE disease activity. The dopamine agonist bromocriptine, which inhibits pituitary secretion of prolactin, has been shown in a variety of small animal and human trials to reduce disease activity in SLE [283] . The optimization of the therapeutical use of steroid hormones such as glucocorticoids, estrogens or vitamin D hormone is now possible in autoimmune disease following recent basic and clinical research achievements [455] .
These are but a few examples of the numerous cases of hormonal therapy of various diseases which are reviewed in this paper.
Finally, neuroimmune mechanism fulfill physiological functions, e.g. cytokines fulfill important functions in neurophysiology [456] and indeed the physiology of every organ and tissue in the body [457] . 
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